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ABSTRACT OF THE DISSERTATION 
 
Modeling Treatment Outcomes in Eating Disorders: 
Does Therapist Feedback Support Individually Tailored Service Allocation? 
 
by 
Kathryn Grace Truitt 
Doctor of Philosophy, Graduate Program in Clinical Psychology 
Loma Linda University, March 2011 
David A. Vermeersch, Chairperson 
 
Eating disorders are notoriously difficult and costly to treat, with only 40% of 
individuals with an eating disorder making a full recovery. Individually Tailored Service 
Allocation provides a dynamic treatment model defined by empirically accepted theory 
and consistently informed by data provided by the patient. The use of patient feedback 
allows for the tailoring of individual treatment plans to meet the unique and varied needs 
of each patient. Hierarchical Linear Modeling was used to examine the effect of 
Individually Tailored Service Allocation on eating disorder treatment outcomes.  A total 
of 51 adult women meeting diagnostic criteria for an eating disorder participated in this 
study. Participants were randomly assigned to treatment as usual or individually tailored 
treatment groups. Changes in psychological dysfunction and distress were measured bi-
weekly throughout the course of treatment using the Outcome Questionnaire 45. The 
results of this study indicate variability in levels of global psychological dysfunction 
(both within and between subjects) throughout the course of treatment appear to be the 
norm, rather than an exception, and this variability is related to eating disorder treatment 
outcomes. The choice of treatment methodology and level of Individually Tailored 
Service Allocation has the ability to drastically shift treatment outcomes.  
1 
Introduction  
 
 
 
“Eating disorders are one the most troubling behavioral disorders in our 
society. Eating disorders rob girls and young women of their future and, not 
uncommonly, their lives.” (Park, 2007) 
 
The psychological, physical, and social costs of an eating disorder are extremely 
high (Levine & Smolak, 2005). Anorexia nervosa has a projected mortality rate of 5% 
(Birmingham, Su, Hlynsky, Goldner, & Gao, 2005), and lifetime prevalence for bulimia 
nervosa is estimated to be 5% for females (Lewinsohn, Striegel-Moore, & Seeley, 2000). 
Individuals suffering from an eating disorder have a suicide risk that is 50 times higher 
than that of the general population (Park, 2007). Treatment is often costly and slow, with 
estimates for length of recovery ranging from 57 to 79 months (APA Work Group on 
Eating Disorders, 2000). Only 40% of individuals diagnosed with an eating disorder, 
even with treatment, will recover, with 20% obtaining partial recovery, experiencing no 
recovery, or dying.  Even more disconcerting, only 1 in 10 males or females suffering 
from an eating disorder will get treatment for it. Only 35% of those 1 in 10 individuals 
will receive treatment at a facility that specializes in treating eating disorders 
(Noordenbox, 2002). 
Three primary eating disorders are recognized diagnostically: anorexia nervosa, 
bulimia nervosa, and eating disorder not otherwise specified (NOS). Of these three 
diagnoses, there are 10 subtypes of eating disorders, none of which are a completely 
separate diagnostic and treatable entity from the others (Wonderlich, Joiner, Keel, 
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Williamson, & Crosby, 2007). To further complicate the presentation of an individual 
with an eating disorder, such individuals typically present with both Axis I and Axis II 
psychiatric disorders, including anxiety, depression, body dysmorphic disorder, obsessive 
compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and substance abuse 
disorders (Costin, 1999; Kaye, Bulik, Thorton, Barbarich, & Masters, 2004). Eating 
disorders are also typically accompanied by neurological and cardiovascular difficulties 
(Chavez & Insel, 2007). Despite hundreds of research investigations examining etiology, 
comorbidities, correlating factors, neurological presentations, treatment, and outcome 
results, there are still more questions than answers about eating disorders.  
Eating disorders are particularly troubling due to their chronic state and nebulous 
psychological presentation. There are no commonly accepted and empirically 
proven psychotherapeutic interventions for the treatment of either anorexia or bulimia. 
There is a dearth of objective research studies examining the effectiveness of anorexia 
treatments. In the few studies that do try to examine anorexia treatments effectively, no 
single treatment paradigm has demonstrated a clear advantage over the others (Chavez & 
Insel, 2007). Research on anorexia faces many large hurdles impeding the development 
and implementation of evidence-based treatments.  
The study of the treatment of bulimia has, fortunately, better results. Fluoxetine, a 
serotonin reuptake inhibitor, has shown promising results in reducing binge/purge 
behaviors, improving food and eating-related attitudes, as well as reducing the rate of 
short-term relapse (Beaumont, Russell, Touyz, Buckley, Lowinger, et al., 1997; 
Goldstein, Wilson, Thompson, Potvin, & Rampey, 1995; Romano, Halmi, Sarkar, Koke, 
& Lee, 2002). Fluoxetine is currently the only Food and Drug Administration-approved 
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treatment for any eating disorder. A variety of psychotherapeutic interventions have been 
examined for effectiveness in the treatment of bulimia, including cognitive behavioral 
therapy (CBT), interpersonal therapy (IPT), and dialectical behavioral therapy (DBT), 
amongst others. CBT is currently considered the most effective form of treatment for 
bulimia, preferably alongside the use of an antidepressant (Walsh, Fairburn, Mickley, 
Sysko, & Parides, 2004). Unfortunately, much like in the treatment of anorexia, there are 
still many more treatment nonresponders than responders, indicating a continued need for 
further research into treatments, comorbid factors and diagnoses, and their etiology. 
Additionally, although numerous eating disorder interventions have been evaluated, the 
majority have only achieved modest success. A recent meta-analysis conducted by Stice 
et al. (2007) reported that out of 51 eating disorder treatment programs, only 9 served to 
reduce risk factors and/or the symptoms of eating disorders and have these changes still 
be present at follow-up. 
Almost all treatment methodologies for eating disorders are taken from treatment 
protocols for other disorders. In large part this is because so little is understood about the 
underlying neurological and pathophysiological presentations of eating disorders. 
 Understanding an eating disorder is difficult, if not impossible, without a 
comprehensive picture of the role of interpersonal, intrapersonal, sociological, cultural, 
and physiological factors in the disorder. While large amounts of research investigating 
food- and body-related factors have been conducted, it was not until very recently that the 
pathophysiology of eating disorders was considered (Chavez & Insel, 2007).  
Recent investigations into the neurological underpinnings of mental disorders 
have illuminated abnormal activity in the central nervous system, encouraging some 
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scientists to claim that a mental illness may, in fact, be a brain disorder. Investigators 
have begun to supplement the observational and behavioral tools of psychology with the 
tools more commonly reserved for medical illness, i.e., positron emission tomography 
(PET) scans, functional magnetic resonance imaging (fMRI), and single photon emission 
computed tomography (SPECT), amongst others. It is hoped that insights provided by 
these modern tools of neuroscience will provide more information on how to effectively 
treat eating disorders.  
Modern advances in our understanding of these illnesses give us the opportunity 
to re-evaluate the etiology of this disease. For instance, weight loss and binge/purge 
cycles are now felt to be the outward manifestation of more significant underlying 
psychological illness. Although these are the features still used to identify and diagnose 
the disorders based on Diagnostic and Statistical Manual of Mental Disorders, 4th 
Edition, Text Revision (DSM-IV-TR) categories, there is the possibility that the grouping 
of symptoms into classification lists by behavior is overly simplified. Numerous studies 
have elucidated many other factors in eating disorders, including not only biological 
factors such as genetic predisposition and neurological dysfunction, but also personality 
characteristics, abuse histories, traumatic incidents, and developmental challenges 
(Anderluh et al., 2003; Berretinni, 2004; Fairburn & Harrison, 2003; Keel & Klump, 
2003). These different etiological factors are readily apparent in the manifestation of 
eating disorder symptomology.  
While each patient presents with similar symptoms causing him or her to be 
recognized as having an eating disorder, there can be different underlying causes of the 
eating disorder. For instance, patients may present with childhood abuse/PTSD, OCD 
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features, depression, or anxiety as the key contributing factor. As these patients receive 
treatment, therapy is often tailored to assist the patient in resolving these particular issues 
as well as address more generalized symptoms such as body image and nutrition. Due to 
the large variety of underlying factors resulting in an eating disorder, it may be necessary 
to explore response to treatment by gauging underlying etiologic patterns rather than 
seeking a single therapeutic technique to treat all patients. Tailoring therapy to the unique 
etiology of each patient may prove to be the most efficacious form of treatment for eating 
disorders. Ultimately, as stated by de la Rie, Noordenbos, Donker, and Furth (2006), 
“Evidence based clinical practice regarding treatment for any eating disorder should be 
founded on research on the efficacy, effectiveness, and efficiency of different treatment 
options as well as the clinical and physical circumstances and the patient’s preferences.”  
The current diagnostic categories for eating disorders do not take into 
consideration the variety of symptom presentations and possible etiologic patterns of 
each individual. There are two primary diagnostic systems used throughout the world, the 
Diagnostic and Statistical Manual of Mental Disorders (4th ed; DSM-IV; American 
Psychiatric Association, 1994) and the International Statistical Classification of Diseases 
and Related Health Problems (10th revision; ICD-10; World Health Organization, 1992). 
Despite the careful consideration and review that both manuals undergo before 
publication, there is rising speculation that the real-world applicability and validity of the 
DSM-IV categories are limited (Wonderlich, Joiner, Keel, Williamson, & Crosby, 2007). 
In particular, the diagnostic categories of eating disorders are best interpreted as 
diagnostic constructs that are open to change and are easily falsifiable (Skinner, 1986), 
instead of distinct disease entities.  
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Proposed Etiology of Eating Disorders  
 
The etiology of eating disorders is virtually unknown. Numerous possibilities 
have been suggested, such as genetic predisposition, cultural influences, neurotransmitter 
imbalances, temperament, and familial influences (Smolak & Levine, 2006). Explanatory 
theories for the etiology of eating disorders are widespread and just as varied. As Stiegler 
(2007) claimed, “Arguably, eating disorders have inspired more shifts in explanatory 
paradigms over a shorter span of time than have any other class of syndromes in the 
history of psychiatry.” Anorexia was initially considered to be the result of the 
“refrigerator mom” who drove her children into food refusal as their only means of self-
assertion. Bulimia was initially seen as a “protest” against parental hostility or even 
cruelty that would lead afflicted girls to pursue unmet needs through rampant binging 
followed by a rejection of what they were given with compensatory purging (Stiegler, 
2007). Throughout the 1980s and 1990s, the paradigm moved to one of conceptualizing 
eating disorders as culture-bound syndromes, driven by western society’s over-emphasis 
on how one looks, how one behaves, and the overwhelming media presence. Again, new 
research arose that found these theories lacking. Incidents of eating disorders began to 
appear in cultures never touched by western societies, and historical investigations found 
eating disorders in cultures not subject to modern mores or media. New theories seek to 
link anorexia and bulimia to abnormalities in the brain and genetic causes.  
There may be no single explanation for eating disorders. As with their 
multifaceted presentation, complete with numerous possible comorbidities, manifesting 
in a variety of cultures, ages, and developmental histories, their theoretical presentation 
may be equally complex. Eating disorders may be the result of interplay between nature 
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and nurture. The complexities in etiology only serve to further complicate the healthcare 
community’s attempts to find successful prevention and treatment strategies. Therefore, a 
thorough investigation of the possible biopsychosocial indicators of eating disorders is 
necessary.  
 
Eating Disorder Risk Factors  
Anorexia and bulimia share some general risk factors but are also unique and 
distinct illnesses. Both eating disorders have gender as their most potent risk factor; being 
female places one at much higher risk than being male (Southgate, Tchanturia, & 
Treasure, 2005). Numerous characteristics developed during childhood also place one at 
higher risk for developing an eating disorder, such as traits on the obsessive compulsive 
disorder spectrum or a tendency to internalize events. Certain temperamental traits are 
also highly correlated with eating disorder onset such as compulsivity, characterized by a 
fear of mistakes, perfectionism or rigidity, and emotionality, characterized by neuroticism 
and behavioral inhibition (i.e., shyness and social anxiety; Anderluh, Tchanturia, Rabe-
Hesketh, & Treasure, 2003). Risk factors unique to each disorder tend to include 
appetitive behaviors and body weight. Individuals with anorexia tend to have a poor 
appetite during childhood and a lower than average body weight, with the opposite being 
true in individuals who have bulimia (Southgate et al., 2005).  Individuals with bulimia 
also tend to have more exposure to adverse events in their lives than do those with 
anorexia.  
Anorexia and bulimia appear to have similar factors that trigger the onset of the 
illness. There tends to be some sort of nutritional stress, which can be the result of either 
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a diet, exercise, or an illness that occurs in the context of some distressing life event 
(Southgate et al., 2007). Maintenance of the disorders occurs through a variety of factors, 
where the core operating structures appear to be specific to the type of eating disorder 
developed. According to Schmidt and Treasure (2005), anorexia is maintained through 
the effect of the illness on the individual’s interpersonal relationships as well as the 
secondary gains resultant from the illness. Fairburn and colleagues (1993) developed a 
maintenance model of bulimia. They found that self-esteem based on appraisals of weight 
and shape feeds the inception of the illness. The illness is then maintained through cycles 
of self-perpetuating behavior (i.e., binge/purge) that are intended to counteract low self-
esteem but instead strengthen it. Figure 1 provides a working model, developed by 
Southgate et al. (2005), of eating disorder development and maintenance. 
 
Underlying Neurological and Biological Factors Support a Disruption in 
Collaborative Brain Function  
Anorexia presents as a unique physiological condition, quite different from 
bulimia. Investigative studies using functional magnetic resonance imaging found 
neuronal abnormalities that appear to be specific to anorexia. These abnormalities include 
decreased brain volume (Katzman et al., 1996), diminished cerebral blood flow and 
metabolism (Delvenne et al., 1995), disturbances in event-related potentials (Bradley et 
al., 1997), impaired cognitive performance on tests (Green, Elliman, Wakeling, & 
Rogers, 1996) and altered levels of neurotransmitters (Kaye et al., 1998). These 
abnormalities suggest a physical neural mechanism underlying anorexia. Interestingly, 
Uher et al. (2003) found differences in the neural correlations of individuals suffering  
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Figure 1. Proposed Model of Biopsychosocial Eating Disorder 
Inception and Maintenance (Southgate et al., 2005). 
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from chronic anorexia and individuals who had been recovered from anorexia for a 
minimum of two years. These observed differences may represent changes in brain 
behavior that occurred with the treatment and recovery process; in particular, they may 
represent changes in information and/or cognitive processes.  
While bulimia does not trend toward the chronic course presented by anorexia, 
changes in the central nervous system are observed in the disease. For example, during 
the course of the illness, regional blood flow to the inferior frontal and left temporal 
cortical areas is elevated (Nozoe et al., 1995). It has been posited that these two areas 
play a significant role in the pathophysiology of bulimia. Cerebral blood flood is 
suggested to vary as a function of bulimia’s restricting and binge/purge phases (Hirano et 
al., 1999). Cerebral blood flow correlates with glucose metabolism, which relegates a 
correlation of alterations in blood glucose levels to bulimia (Fox et al., 1988). Frank et al. 
(2000) examined the activity of cerebral blood flow in recovered bulimic individuals and 
found no significant difference from the control subjects. This supports the idea that 
elevated cerebral blood flow in bulimic individuals is inclusive of their pathophysiology. 
Upon recovery, cerebral blood flow will return to that of a non-eating disordered 
individual. This suggests that effective treatment and subsequent recovery should return 
some of the abnormal brain functions associated with bulimia to a more normalized level.  
The unique presentation of these two disorders encourages further investigation 
into the role of neurotransmitters, cerebral blood flow, and other neurological 
foundations. Theories incorporating the inner workings of the brain could help to 
elucidate some of the unknown aspects of these disorders as well as allow for the 
development of new hypotheses in how to best treat and/or measure eating disorders.  
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The brain is composed of highly concentrated overlapping neural networks 
involved in the acts of desiring, seeking out, obtaining, and consuming foods. The 
ventromedial hypothalamus and nucleus accumbens are both highly implicated in these 
networks. The nucleus accumbens, in particular, is recognized as the major reward center 
of the brain. This nucleus is modulated by numerous neurotransmitters including 
dopamine, glutamate, and opioid neuropeptides (Simansky, 2005). Addiction research 
shows that stimulating these neural pathways and neurotransmitters may lead to 
physiological and behavioral pathology often combined with cravings, obsession, and 
overconsumption.  
Dopamine action in the nucleus accumbens is of particular interest in addiction 
research. Some eating disorder theorists suggest that self-administration of substances 
and feeding behaviors can be considered in the same category as substance or alcohol 
abuse due to similarities in animal behavior with self-administration of these substances 
(Wise, 1997). One study found that both food deprivation (mimicking anorexia) and 
overeating (mimicking binge-eating) increased dopamine activity in the lateral 
hypothalamus, which led to increased activation in the nucleus accumbens. This 
behavioral effect is similar to the activation seen when rats lever-press for electrical 
stimulation of their medial forebrain bundle, of which both the lateral hypothalamus and 
nucleus accumbens are a part (Hernandez & Hoebel, 1988). In light of these findings, 
Davis and Woodside (2002) examined the role of anhedonia in individuals with eating 
disorders. They reported that anorexic individuals had significantly higher levels of 
anhedonia compared to bulimic individuals. Anhedonia, a diminished ability to 
experience pleasure, stems from dopamine interaction with the mesolimbic structures 
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making up the reward pathway. This finding suggests that the compulsive and addictive 
nature of anorexia may have roots in decreased dopamine activity in the reward centers of 
the brain. As previously mentioned, food deprivation does increase levels of dopamine in 
the medial forebrain bundle, demonstrating that the anorexic may be behaviorally self-
medicating for this deficiency.  
Some theorists claim that eating-disordered behaviors present with the same 
characteristics as the auto-addiction opioid theory. This theory, commonly used to 
describe addiction, proposes that behaviors are undertaken, such as starving or 
overexercising, to increase the levels of ß-endorphins in the body. These ß-endorphins are 
biologically identical to exogenous opioids; thus, these behaviors take on an addictive 
quality due to their ability to stimulate the reward centers in the brain (Marrazzi & Luby, 
1986).  
As previously mentioned, the brain is composed of a complex network of 
neurotransmitter pathways with many neurotransmitters interacting at different levels. 
Serotonin (5-HT) is the primary neurotransmitter implicated in eating disorder pathology. 
Disturbances in 5-HT levels have long been implicated in eating disorder pathology. 5-
HT is implicated in a variety of psychopathologies commonly comorbid to eating 
disorders. For example, 5-HT has been implicated in personality and temperament traits 
such as behavioral inhibition, harm avoidance, and borderline personality disorder (Paris, 
Zweig-Frank, Kin, Schwartz, Steiger, & Nair, 2003). 5-HT is also implicated in 
numerous psychiatric conditions such as anxiety, fear, obsession (Barr, Goodman, Price, 
McDougle, & Charney, 1992), and depression (Grahame-Smith, 1992). Similarly, 
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serotonin (5-HT) disturbances have long been documented in individuals with eating 
disorders.    
Research has found a significant negative correlation between eating-disordered 
behaviors and 5-HT levels. This supports the idea that eating-disordered behavior serves 
as a self-medication against high levels of anxiety. Kaye (1999) proposed that this is 
because the eating-disordered behavior increases the level of 5-HT in an overactive 5-HT 
system. Recovered bulimic individuals still exhibit disturbances in the 5-HT system, even 
after long-term recovery (Kaye et al., 1999; Smith et al., 1999). Disturbances in these 
neurotransmitters, amongst others, may play a large role in the etiology of an eating 
disorder (Kaye, 1999). Finally, 5-HT plays a role in satiety after food consumption (King, 
2006). A recent investigation by Kaye, Frank, Bailer, et al. (2006) reported disturbances 
in 5-HT1A and 5-HT2A receptors as well as in the 5-HT transporter in anorexic and 
bulimic individuals. These disturbances are reported over the long term in individuals 
who were previously ill and recovered from anorexia or bulimia (Kaye et al., 1999; Smith 
et al., 1999).  
5-HT1A is purported to play a role in mood and impulse control, anxiety, feeding 
behavior, and selective serotonin reuptake inhibitor (SSRI) response. Using positron 
emission tomography (PET), Kaye et al. (2005) found increased receptor activity of 5-
HT1A in prefrontal, medial, and lateral orbital frontal, parietal, lateral temporal, and 
supra- and pregenual cingulated regions, as well as in the dorsal raphe nuclei in recovered 
anorexic-bulimic and bulimic individuals. These findings, again, exemplify the long-term 
changes in 5-HT receptor activity in the brain. Recovered anorexics did not show a 
significant difference in 5-HT1A receptor activity relative to control subjects, perhaps 
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providing insight as to why bulimic individuals are responsive to SSRIs but anorexic 
individuals are not. To date, increased 5-HT1A receptor activity has only been found in 
individuals exhibiting bulimic symptomology.  
The 5-HT2A receptor is implicated in the regulation of mood, anxiety, 
antidepressant action, and feeding (Barnes & Sharp, 1999). Kaye et al. (2005) reported 
reduced 5-HT2A receptor activity in the parietal, occipital, and subgenual cortex in both 
recovered anorexic-bulimics and anorexics. Additionally, recovered anorexics showed 
reduced 5-HT2A activity in the mesial temporal region and pregenual cingulate. Other 
investigators reported a significant reduction in 5-HT2A receptor activity in the left 
frontal cortex, the occipital cortex, and the parietal cortex in ill anorexics (Audenart et al., 
2003). Bulimics were found to have normal 5-HT2A activity (Goethals et al., 2004). 
While these findings are consistent with the speculation of 5-HT2A disturbances in 
anorexia, the disturbances of 5-HT2A in bulimia are less clear.  
Research consistently shows disturbances in 5-HT1A and 5-HT2A receptor 
activity in recovered eating-disordered individuals. Similarly, the disturbances in 
dopamine (DA) activity in the brains of eating-disordered individuals are becoming well 
documented. It is currently unknown whether neurotransmitter disturbances precede the 
eating disorder or the eating disorder causes the disturbance, but the involvement of these 
neurotransmitters in the eating disorder is evident. Evidence concerning the effect of 
disturbances in synaptic pruning in adolescence and the dysregulation in the 
hypothalamic-pituitary-adrenal axis (HPA axis) further support these hypotheses. Kaye et 
al. (2005) hypothesized that eating-disordered individuals have a dysregulation in the 
function of their neural circuitry, most likely relating to disturbances in any number of 
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the components of the circuit. These disturbances could be in the form of interacting 
receptors or in the molecules forming the intracellular communication translating the 
receptor signals. While it is known that receptor activity is a combination of many factors 
such as neuronal firing, exocytosis, reuptake, and other intracellular mechanisms, the 
technology to pinpoint exactly where in this process the disturbance lies is still 
unavailable. Part of the challenge facing the pharmaceutical community in creating 
effective drugs to treat eating disorders is diagnosing how to best normalize the 
disruption in neurotransmitter activity.  
 
Neuropsychological Models of Brain Development and Their Impact on EDOs  
There are currently numerous models of the potential vulnerabilities and risk 
factors for eating disorders. The focus has recently moved toward the examination of the 
neurological, genetic, and biological underpinnings of these disorders. Bulimia and 
anorexia present with different underlying physiological mechanisms. These differences 
may explain why anorexia and bulimia respond to psychopharmaceutical and therapeutic 
interventions differently. For example, bulimia is generally more responsive to fluoxetine 
than anorexia. Anorexia is more likely to be a chronic condition than bulimia. 
Furthermore, numerous investigations found that individuals suffering from anorexia tend 
to be repeatedly hospitalized (Keel & Klump, 2003; Milos et al., 2003).  
One neurodevelopmental model of eating disorders relies on the HPA axis as a 
primary mechanism underlying the chronic stress and maladaptive coping strategies seen 
in individuals with eating disorders (Connan, Campbell, Katzman, Lightman, & Treasure, 
2003). This model stresses the importance of genetic factors, childhood experiences, and 
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the biopsychosocial environment in modifying the HPA axis. These alterations lead to 
maladaptive cognitive, emotional, and social functioning. The HPA axis, along with its 
control mechanisms located in the central nervous system, enables the metabolic 
resources necessary for all of our behaviors (Lovallo & Thomas, 2005). Operating in all 
stages of life, from sleep to severe stress, the HPA axis is also responsive to our private 
emotions and thoughts. Research indicates that the HPA axis produces large stress 
responses when exposed to novel stimuli but that with further exposure, these responses 
decrease. Interestingly, though, Mason (1968) claimed that the stressfulness of a response 
is not purely reflexive but is also modified by previous experience and the nature of the 
environment.  
This is important to consider in eating disorders because when an individual is 
exposed to consistently traumatic experiences, the HPA axis is altered in response to the 
high levels of glucocorticoids necessary to maintain a state of alertness (i.e., a state of 
fight or flight). Over time, high levels of glucocorticoids damage the hippocampus, 
impairing memory formation as well as affecting levels of epinephrine and cortisol. 
These changes result in a disruption in the ability to maintain normal cognitive 
functioning (Lovallo & Thomas, 2005). The HPA axis also plays a large role in the 
regulation of 5-HT neurotransmitters, with chronic stress leading to decreases in 
hippocampal 5-HT1a and 5-HT1b and an increase in cortical 5-HT2a. These changes, as 
will be illuminated later, have been noted to be significant in individuals with an eating 
disorder and are also highly correlated with suicidal behaviors (Lopez, Vazquez, 
Chalmers, & Watson, 1997).  
Adolescence is an extremely important time for brain development. During the 
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adolescent years, the brain begins the process of synaptic pruning, resulting in the 
elaborate branching-out of dendrites and increasing levels of myelination. Synaptic 
pruning is associated with vital refinements to brain systems through increasing 
efficiency and efficacy by removing redundant neural connections (Southgate et al., 
2005). Myelination allows for more rapid communication throughout the brain by 
speeding up neural transmission. These changes allow for the collaboration of widely 
dispersed circuitry throughout the brain and the integration of a variety of brain regions, 
ultimately allowing top-down cognitive control of behavior (Luna & Sweeney, 2004). 
The enhanced communication between areas of the brain such as the prefrontal cortex, 
basal ganglia, thalamus, and frontal cortex set the stage for the maturation of the brain in 
such a way that reflective and inhibitory processes are more consistent and efficient. This 
stage of brain development in adolescence leads to the development of “collaborative 
brain function.”  
Synaptic pruning and the HPA axis are implicated as causal factors in developing 
a vulnerability to an eating disorder. Southgate and colleagues (2005) proposed that 
because of the alteration in the HPA axis, leading to a poor coping response to stress, 
certain individuals are in a persistent state of intense and demanding emotional distress. 
This state, when it persists through adolescence, interrupts the process of synaptic 
pruning, thereby disrupting the brain’s transition from localized function to collaborative 
brain function. Secondary effects commonly seen in eating disorders also play a role in 
disrupting this critical time of brain development. Poor nutrition eventually disturbs the 
regular maturational processes of the brain and can also disrupt normal hormonal 
changes. The effects of a lack of complete development of collaborative brain function 
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can cause specific behaviors to arise that are often noted in an individual with an eating 
disorder. For example, behavioral focus may be on internal or external stimuli that are 
immediately gratifying or rewarding but may be harmful in the long run. The lack of 
integrative brain function inhibits the top-down control of behavior and therefore may 
lead to the preservation of maladaptive behaviors.  
 
Role of the Social Information Processing Network in Eating Disorders (Nelson et 
al., 2005)  
The neurological underpinnings of an eating disorder play an important role in 
how individuals with anorexia and bulimia interact with and perceive the world around 
them. Nelson and colleagues (2005) introduced the social information processing 
network (SIPN) to elucidate the variety of factors interacting to define how an individual 
experiences the world. The SIPN is composed of cognitive, affective, and detection nodes 
that mature during the process of synaptic pruning. During adolescence, the SIPN is 
modulated by gonadal hormones. With the onset of puberty, changes in hormones impact 
the cells in the affective node, thus affecting the intensity and valence of social stimuli. A 
hypersensitivity to interpersonal relations is created and can lead to increased emotional 
responsiveness in scenarios concerning self-esteem, acceptance, rejection, and motivation 
(Southgate et al., 2005). Research has found eating disorders to often be triggered by 
interpersonal problems, and it is possible that lack of maturation in the SIPN forms a 
neural vulnerability in the affective realm that leaves one susceptible to eating-disordered 
behavior.  
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Researchers have recently begun investigating executive functioning in 
individuals with eating disorders. Particular focus has been on inhibitory processing in 
order to examine the role of impulsivity in individuals with anorexia and bulimia. 
Congruent with the clinical presentation of individuals with anorexia, restricting subtype, 
there are increased levels of inhibitory processing. Interestingly, individuals with bulimia 
and those with anorexia, binge/purge subtype tend to have poorer inhibitory processing, 
hinting at higher levels of impulsivity (Rubia, Smith, & Taylor, 2005). Numerous other 
investigations into set-shifting abilities and cognitive flexibility consistently show deficits 
in overall executive functioning. Individuals with eating disorders appear to be able to 
inhibit or withhold the activation of new behaviors and may even have difficulty 
beginning new behaviors but have an extremely difficult time disrupting or stopping 
ongoing behaviors. From a wider perspective, these disorders can be conceptualized as 
being composed of a continuous cycle of behaviors that is difficult to break, particularly 
for individuals who have impediments in executive functioning.  
Gillberg and colleagues (1996) suggested that individuals with anorexia struggle 
with goal-directed behavior. Their research indicated that under certain circumstances, 
individuals with anorexia will display a cognitive style that ultimately hampers task 
completion. Goal directedness is characterized by an individual’s ability to take a step 
back from the minute details and see the bigger picture. Individuals with anorexia tend to 
have superior performance in attending to details and excelling in tasks requiring directed 
effort than those with bulimia and nonclinical controls. On the other side of this cognitive 
continuum, individuals with anorexia tend to have very weak performance with respect to 
incidental learning. Frith (1989) labeled this cognitive style “weak central coherence” in 
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which these individuals persist on focusing on details even when the instructions of the 
task at hand call for global information processing. These behaviors are adaptive neither 
for the task at hand nor for normal, healthy functioning. The cognitive style of an 
individual with anorexia reflects an overwhelming tendency to use localized rather than 
distributed information processing networks (Southgate et al., 2005). These findings, 
again, reflect the importance of synaptic pruning during the adolescent’s development as 
well as the impact of a dysregulated HPA axis.  
It has long been accepted that individuals with eating disorders struggle with 
emotional experiences, expression, and regulation (Kucharska-Pietura, Nickolauo, 
Marsiak, & Treasure, 2004; Schmidt, Jiwany, & Treasure, 1993; Zonnevylle-Bendek, van 
Goozen, Cohen-Kettenis, van Elburg, de Windt, & Stevelmans, 2004; Zonnevylle-
Bendek, van Goozen, Cohen-Kettenis, van Elburg, & van Engleand, 2002). Individuals 
with eating disorders also tend to have comorbid alexithymia, suggesting poor emotional 
intelligence. Furthermore, Friederlich and colleagues (2005) found a disturbance in the 
emotional processing of pleasant stimuli using a startle eye blink paradigm. Both 
anorexics and bulimics failed to show the activation in the appetitive-motivational system 
that control subjects portrayed when shown positive stimuli. Anorexics tend to also have 
further emotional dysregulation that becomes a pervasive form of anhedonia and disrupts 
their internal reward system, therefore limiting or completely eliminating their experience 
of pleasure (Davis & Woodside, 2002).  
Animal studies have evidenced that lesions in the ventral striatum, which includes 
the nucleus accumbens, block response to the startle reflex in positive states (Koch, 
Schmid, & Schnitzler, 1996), as does destroying dopaminergic neurons in this same 
21 
region. This information becomes important when one is considering the role of the 
dopamine systems in eating disorders. Impaired dopamine function is found in both 
bulimic and anorexic individuals. Individuals who have recovered from anorexia still 
display increased D2/D3 receptor binding in the antero-ventral striatum (Frank et al., 
2005). These abnormalities may be responsible for the low appetitive drive and general 
anhedonic response seen in individuals with anorexia. Contrastingly, individuals with 
bulimia portray reduced D2/D3 binding in the antero-ventral striatum, similar to what is 
noted in individuals with substance abuse (Wang, Volkow, Logan, et al., 2004). Such 
neurological deficiencies and cognitive dysfunctions inevitably impact individuals’ 
perception of the world around them. 
 
Social and Cultural Factors in Eating Disorder Development and Maintenance  
After a review of the literature, Smolak and Levine (2006) reported strong 
evidence suggesting that weight concerns, dieting, and body dissatisfaction predict the 
inception of eating pathology. Interestingly, a large meta-analysis performed by Keel and 
Klump (2003) found evidence suggesting that bulimia is a culture-bound syndrome, 
while anorexia is not (although cultural influences are found to aid in the maintenance of 
anorexia). The results of both of these investigations hint at the important role of societal 
and cultural influences in eating disorders. In light of these findings, it is unsurprising 
that new hypotheses regarding the roles of societal and cultural factors in eating disorder 
conceptualization are gaining momentum. Two newer hypotheses, the eating disorder 
continuum hypothesis and social cognitive theory, offer a viable beginning for the 
conceptualization of eating disorder etiology. 
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The eating disorder continuum hypothesis is based on the concept that disturbed 
eating behaviors are a matter of degree (Scarano & Kalodner-Martin, 1994; Tylka & 
Subich, 1999). It places unrestrained (or asymptomatic eating) at one end of the 
continuum and clinical eating disorders (or anorexia/bulimia) at the other end of the 
continuum. Between the two endpoints lie milder forms of disordered eating. Literature 
supports the hypothesis that certain characteristics of clinical eating disorders align 
themselves with the eating disorder continuum hypothesis. Because a majority of women 
divulge the use of unhealthy eating behaviors and suffer psychological and physiological 
consequences as a result, numerous clinicians have suggested that eating disorders ought 
to be conceptualized on a continuum (Scarano & Kalodner-Martin, 1994; Tylka & 
Subich, 1999). These clinicians note that examining different levels of eating disturbance 
may illuminate etiological factors involved in the development and treatment of eating 
disorders (Tylka & Subich, 1999). The eating disorder continuum hypothesis also sheds 
light on the role of social-cultural factors in eating disorders.  
 Scarano and Kalodner-Martin (1994) reported that women who exhibit various 
eating disturbances have similar psychological and behavioral characteristics as 
individuals with eating disorders, differing only in terms of severity. For example, body 
dissatisfaction, feeling fat, food preoccupation, weight preoccupation, and the fear of 
becoming fat increase as an individual’s level of disturbed eating increases. Quantitative 
differences have been similarly noted between subjects occupied with clinical, 
subclinical, and unrestrained eating in the areas of interoceptive awareness, interpersonal 
relationships, and feelings of ineffectiveness; difficulties in these arenas increase as 
disturbed eating behaviors increase. More recently, Tylka and Subich (1999) examined 
23 
personality and cognitive facets commonly found in eating disorders along the eating 
disorder continuum. Their study further highlighted the differences between the 
asymptomatic, symptomatic, and eating disorder continuum groups, finding a linear 
relationship amongst the three groups. Similarly, they found a linear relationship with 
internal dieting locus of control and internalization of the thin-ideal stereotype (Figure 2).  
In light of the large influence of society, culture, and the continuum of eating 
disorder pathology, it is important to examine the role of the environment in the 
development of an eating disorder. For example, Becker et al. (2002) assessed the effect 
of the introduction of television on disordered eating behaviors in a Fijian population 
with no previous media exposure. With the introduction of television to this culture, 
disordered eating behaviors and attitudes rose significantly. This investigation provides a 
clear indicator of the negative impact of television, especially in influencing body-image  
 
 
Figure 2. Likelihood of a Diet Progressing Into an Eating Disorder. 
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schemas (Figure 3). Nichter and Nichter (1991) asked adolescent girls to describe their 
ideal female form. The girls significantly endorsed a female who was 5 ft 7 inches, 100 
lbs, and a size 5. The Body Mass Index (BMI) for their idealized female is 15.61, hugely 
below the recommended minimum weight of 118 lbs (BMI 18.5) for someone who is 5 ft 
7 inches. The idealized female described by these adolescents would easily meet criteria 
for anorexia. Clearly, a normal adolescent girl cannot healthfully fit this idealized model. 
Yet according to this study, it is one of the main factors in the social status quo among 
adolescent females.  
The discrepancy between girls’ true forms and the idealized form may play a 
significant role in their self-perception (Levine & Smolak, 1998; Smolak & Levine, 
1996). The more importance placed on this discrepancy, the larger the tendency toward 
eating-disordered behavior. Correspondingly, some researchers have proposed that the 
pressure to be thin influences two variables core to creating eating-disordered behavior: 
the internalization of the thin ideal and disturbance in body image (Stice, Nemeroff, & 
Shaw, 1996). Because the standard of thinness promoted by society is impossible for 
most women to achieve, they are left feeling negative about their own bodies. This 
negativity results in more body-image disturbance. As Frederickson and Roberts (1997) 
pointed out, women in America are often socially conditioned to base their sense of self-
worth on their appearance. It is now considered normative for women to have a moderate 
degree of body dissatisfaction and to use diet and exercise to manipulate their weight and 
body in an attempt to conform to the portrayed media ideal (Gordon, 2000).  
An overwhelming amount of evidence suggests that many of the factors involved in the 
maintenance of an eating disorder are learned behaviors (Smolak & Levine, 2006).  
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Figure 3. Body Satisfaction in American Women 
After Viewing Media Images. 
 
 
 
Because of the apparent role of modeled and learned behaviors in eating disorder 
pathology, numerous researchers are now ascribing to a sociocultural model of eating-
disorder conceptualization based on social cognitive theory (SCT; Bandura, 1986). SCT 
views behavior as the result of transactions between three factors: (a) an individual’s 
cognitive and emotional processes; (b) patterns of behavior and competencies; and (c) the 
context or environment. The compilation of these three factors creates the learned 
behaviors and cognitions through which an individual navigates the world, known as an 
individual’s schema. A schema represents the mental structures that help people manage 
their interactions with the environment in consistent, stable, and meaningful ways (Solso, 
MacLin, & MacLin, 2005).  
Research on eating disorders supports the three factors of SCT in its 
conceptualization of eating disorder pathology. For example, Frederickson and Roberts 
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(1997) suggest that women are socialized to equate self-worth with their appearance. This 
objectification of themselves is the result of psychological variables working in 
conjunction with sociocultural factors, leading to body shame and body-image 
disturbance. Similarly, it has been suggested that pressures to be thin are predictive of 
negative affect and poor social support in women (Maine, 2000; Pipher, 1994; 
Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999). Research utilizing the eating 
disorder continuum hypothesis supports these suggestions. Stice et al. (1996) found that 
pressure to be thin predicts the unique variance in body dissatisfaction, even beyond the 
variance accounted for in the internalizing of the stereotypical thin ideal.  
It is important to note that while the environment and culture may have a strong 
impact on eating disorder inception and maintenance, they have only an indirect 
relationship with actual eating disorder psychopathology. The other two factors of SCT, 
an individual’s cognitive and emotional processes and patterns of behavior, also play a 
key role in an eating disorder’s etiology. While each of the three factors of SCT has a role 
in eating-disordered behavior and pathology, the result is a specific type of schema 
present in eating-disordered individuals (Levine & Smolak, 2006). This schema, called a 
body image schema, organizes various mechanisms of body image such as shape, weight, 
appearance, and health (Smolak & Levine, 2006). The body image schema is the result of 
the interplay of SCT factors, particularly highlighting experiences and cognitions around 
teasing, mass media, standards of beauty, and the thin ideal in the individual’s 
environment. The prevalence of the expectations and ideals in westernized cultures and 
societies support the role of the sociocultural model of eating disorders in the eating 
disorder continuum model hypothesis. The schema is not necessarily applied to every 
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interaction an individual has, but it is activated in many normal, everyday interactions 
such as looking in the mirror, meeting someone new for the first time, shopping for new 
clothes, being presented with certain foods, and/or spending time with friends.  
The activation of the body image schema results in internal dialogues involving 
personal interpretations, thoughts, and conclusions about different interactions and 
situations (Cash, 1997). For someone with a negative body image schema, this internal 
dialogue represents a disparity between an investment in the value of a thinner shape or 
lower weight and an individual’s self-perception. This disparity is often seen in 
individuals who are at risk for disordered eating (Smolak & Levine, 2006)—hence the 
application of SCT to eating-disorder conceptualization. Ainsworth, Waller, and Kennedy 
(2002) suggested that bulimic behaviors were often engaged in order to “block” the 
aversive body image schema. Similarly, Stein and Corte (2003) argued that a disturbed 
body image motivates eating, body, and weight attitudes characterizing both anorexia and 
bulimia. They also found that women with a negative body image schema and few 
positive self-concepts were more vulnerable to societal commentary about food and body 
concerns as well as the thin ideal. This further supports the strong impact of cultural and 
societal ideals.  
One of the key roles of the body image schema in eating-disorder maintenance is 
that it creates a cyclical and self-reinforcing thought process (Smolak & Levine, 2006). 
The bias inherent in the negative body image schema controls individuals’ everyday 
interactions with the world and themselves. Behaviors resulting from the thought 
processes wrapped up in the schema often lessen the immediate negative affect attached 
to the schema but have the long-term consequence of further strengthening the bias 
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(Smolak & Levine, 2006). The result of this cycle is the acquisition of eating-disordered 
pathology in a previously vulnerable individual or the worsening of pathology in an 
already-afflicted individual.  
Tylka and Subich (2004) suggested five variables active in eating disorder 
vulnerability. The higher an individual’s loading on these factors, the more apt he or she 
is to have eating-disordered behaviors or pathology. The five factors are (a) body image 
disturbance, (b) the internalization of the thin ideal, (c) poor family social support, (d) 
poor friend social support, and (e) negative affect. Tylka and Subich’s model brings 
together not only the environmental and cultural influence of the pressure to be thin, but 
also personal and social variables. The model is a more precise examination of the SCT 
model for eating-disorder conceptualization. This model also lends credence to the eating 
disorder continuum hypothesis by illuminating the fact that not all individuals will have 
strong loadings on all five variables.  
The primary predictor of eating disorder symptomology is body-image 
disturbance (Phelps, Johnston, & Augustyniak, 1999). Researchers have long accepted 
the role of body-image disturbance in eating disorder etiology (Frederickson & Roberts, 
1997; Stice et al., 1996; Thompson et al., 1995; Tylka & Subich, 2004). Numerous 
studies indicate that individuals who have more body image disturbance are more likely 
to attempt to modify their bodies through the use of maladaptive weight-control 
techniques. Furthermore, higher levels of disturbed body image are negatively correlated 
with the ability to identify emotions as well as hunger and satiety signals (i.e., 
interoceptive awareness). Frederickson and Roberts (1997) suggested that the decrease in 
interoceptive awareness is due to the shame an individual feels when he or she has body-
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image disturbance. This shame leads the individual to suppress hunger and satiety cues in 
order to lose weight or otherwise attempt to change his or her body.  
Negative affect presents as both neuroticism and low self-esteem in individuals 
with disordered eating or eating disorders (Tylka & Subich, 2004). Negative affect 
accounts for many of the smaller variables making up the personal affective and 
cognitive aspect of SCT. For example, in Tylka and Subich’s model, negative affect 
subsumes many other variables related to eating disturbances such as anxiety, depression, 
lack of impulse control, maladaptive coping, and irrational cognitions. Low self-esteem 
plays a large role in negative affect and is highly predictive of future eating disorder 
symptomology. Some theorists propose that negative affect is the key predisposing factor 
to internalizing the thin-ideal stereotype (Thompson et al., 1999). Furthermore, negative 
affect has a key role in the disturbed interoceptive awareness experienced by individuals 
with eating disorders. The lack of interoceptive awareness is not only related to the 
avoidance of hunger and satiety cues but, as Tylka and Subich (2004) have suggested, 
also related to the avoidance of all internal states including emotions. This suggestion has 
been supported in examination of the eating disorder continuum hypothesis in high 
school- and college-aged women (Pike, 1995; Tylka & Subich, 1999). Similarly, Mazzeo 
and Espelage (2002) reported that alexithymia, the inability to describe emotions 
verbally, is also a unique predictor of some eating-disorder variance.  
Body-image disturbance and negative affect are at the core of the body-image 
schema. Intertwining these two components leads to a clear vulnerability to eating-
disordered symptomology. When other variables such as poor relational or social support 
factors, genetic factors, and issues relating to trauma are heightened in certain 
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individuals, their predisposition toward having an eating disorder similarly is heightened. 
This conceptualization points to a diathesis-stress model for eating disorders. The eating 
disorder continuum model, in particular, supports a diathesis stress etiology, and it is 
further illuminated by the concepts set forth in SCT, in the body image schema, and 
ultimately in Tylka and Subich’s (2004) multidimensional model of eating disorders.  
Thus far, research has indicated that individuals with eating disorders exhibit 
dysfunctional emotional processing. This dysfunction appears to be correlated with 
appetitive responses generally related to the dopaminergic systems and reward pathways. 
Synaptic pruning and disturbances in the HPA axis also appear to play a role in the 
disruption of the development of collaborative brain function as well as an individual’s 
ability to handle stress in an adaptive way. The combination of these factors hints at 
neurological underpinnings that are suggestive not only of potential vulnerability to 
acquiring an eating disorder, but also, almost certainly, of risk factors in both the onset 
and the maintenance of an eating disorder. These neurological vulnerabilities combine to 
create a biological environment susceptible to the pressures of western society. Today’s 
world is rich with pressures that aid in both the development and maintenance of eating-
disordered thoughts and behaviors. Clearly, effective treatment for an eating disorder 
must target a myriad of variables, often unique to each patient. 
 
 
Treatment of Eating Disorders  
 
The treatment of such multifaceted and unique disorders has challenged the health 
care community for decades, if not centuries. The social, cultural, neurological, and 
biological risk factors and vulnerabilities explored thus far are just the tip of the iceberg. 
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Treatment response can be just as varied as the symptom presentation of these disorders. 
Thus far, this review has highlighted the importance of both the affective and the 
cognitive nodes of the social information processing network (SIPN; Nelson et al., 2005); 
the possibility of intense emotional dysregulation and impulsivity in individuals with 
bulimia, binge/purge subtype; as well as the inhibitory, detail-focused processes of 
individuals with anorexia. Treatment clearly needs to address all of these concerns, be it 
through pharmacotherapy, psychotherapy, or a combination approach. Studies 
investigating the use of pharmacotherapy in lieu of psychotherapy find it less effective, 
with the greatest rates of success seen when antidepressants are paired with 
psychotherapy.   
 
Psychopharmaceutical Treatment of Eating Disorders  
Anorexia and bulimia present a decades-long challenge to the psychiatric 
community. Since their emergence as a significant clinical entity, numerous studies have 
largely resulted in a knowledge base consisting more of “what not to do” than “what we 
should do” for treatment. A variety of medication trials have been performed with reports 
in the literature ranging from case reports of a few patients to the occasional double-
blind, randomized, controlled trial. So far, only fluoxetine has received U.S. Food and 
Drug Administration (FDA) approval for the treatment of bulimia. There is currently no 
FDA-approved drug for the treatment of anorexia, although fluoxetine was found useful 
in the maintenance of recovery for anorexia (Holtkamp et al., 2005).  
The lack of medications in the treatment of eating disorders remains a serious 
concern due to the continued difficulty in treating these patients and the high morbidity 
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and mortality rates resulting from them. Treatment is often costly and slow, with 
estimates of length of recovery ranging from 57 to 79 months (APA Work Group on 
Eating Disorders, 2000). A review of early studies using psychopharmacotherapy to treat 
eating disorders demonstrates a focus on the most serious and acute manifestations 
including malnutrition or weight loss and binge/purge cycles. Unfortunately, decades of 
research using weight gain and decreased binge/purge cycles as primary outcome 
measures in medication trials have provided few treatment options for either illness 
(Krüger & Kennedy, 2000). Although this may also be related to difficulties of studying 
this patient population, treatment providers are left sorely lacking tools to assist in the 
treatment of these serious and potentially lethal mental illnesses.  
Bulimia has the best developed treatment literature for psychopharmacology. 
Studies have mainly focused on the use of selective serotonin reuptake inhibitors (SSRIs) 
for treatment, although anticonvulsants, opiate antagonists, serotonergic agonists, and 
lithium have been investigated for efficacy as well (Mitchell, de Zwann, & Roerig, 2003). 
Bulimic individuals tend to respond best to antidepressants, particularly SSRIs. This 
treatment results in significant reductions in eating-disordered behaviors such as binge 
eating and purging. Not surprisingly, these antidepressants also decrease comorbid 
psychopathologies such as anxiety disorders and affective disorder symptoms. As 
previously mentioned, fluoxetine is the only FDA-approved medication for the treatment 
of bulimia. In light of this, it has received the most attention in terms of research. One 
seminal research study examined patient response to fluoxetine, at 20 mg/day or 60 
mg/day, as compared to a placebo. The higher dose of fluoxetine was reported to be 
visibly superior to the placebo (Fluoxetine Bulimia Collaborative Study Group, 1992).  
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A few small studies have examined the use of other medications as off-
label treatment for bulimia. Topiramate, an anticonvulsant that is proposed to work on 
voltage-gated sodium channels, glutamate receptors, and gamma-Aminobutyric Acid 
(GABA) receptors, has shown some efficacy with bulimic patients (Zhu & Walsh, 2002). 
A case study by Knable (2001) reported a significant decrease in the patient’s weight 
concern as well as a significant decrease in her desire to binge, purge, and self-mutilate 
following the use of topirimate to treat her epilepsy. Much more research is clearly 
needed before efficacy can be claimed for the treatment of bulimia with this medication.  
So far, only two studies have examined the use of opiate antagonists for bulimia 
(Alger, Schwalbers, Bigaouette, Michalek, & Howard, 1991; Mitchell et al., 1989). Both 
studies focused on the use of naltrexone, a drug commonly prescribed to help alcoholics 
stop craving alcohol, in purging bulimics. Naltrexone is a competitive antagonist at the 
mu-opioid and kappa-opioid receptors and thus modulates the dopaminergic mesolimbic 
pathway affecting opiate receptors. The ineffectiveness found with naltrexone for the 
treatment of bulimia is not surprising considering the findings of Davis and Woodside 
(2002), who reported significantly less dopaminergic involvement for the purging 
bulimic than for the anorexic or other subtypes of the bulimic spectrum such as 
compulsive overexercisers.  
Current literature has a dearth of studies examining the long-term efficacy of 
antidepressants on bulimia. This is particularly concerning in light of the aforementioned 
long-term disturbances in serotonergic activity in the brain. Another concern is the lack 
of research examining the different subtypes of bulimia. Current research on bulimia 
typically focuses on the prototypical purging subtype. Exercising bulimics portray 
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different DA activity than do purging bulimics. These differences may affect the efficacy 
of a drug on different bulimic subtypes.  
Psychopharmacology for anorexia initially focused on SSRIs, with some efficacy 
being seen with them for relapse prevention in weight-restored anorexics (Holtkamp, 
2005). A large variety of pharmacotherapy options have been explored with the anorexic 
population such as antipsychotics, narcotic antagonists, antihistamines, lithium, zinc, 
antidepressants, and tetrahydrocannabinol (THC; Attria & Schroeder, 2005; Mitchell et 
al., 2003). New research on the psychopharmacology of anorexia has focused on atypical 
neuroleptics in order to better address the resistance to treatment commonly seen in 
anorexia. The most difficult part of treating an anorexic patient is that such patients 
present with two very serious concerns: the psychopathology of an anorexic and the 
physiological attributes of a person close to emaciation presenting with symptoms such as 
osteoporosis and amenorrhea (Mitchell et al., 2003). Separating the immediate 
physiological concerns from the psychological concerns can be difficult to treat 
psychopharmacologically. As the anorexic individual is restored to a healthy weight, he 
or she may present with very different biological patterns and thus have different 
responses to medications.  
Typical pharmacotherapy for the acute anorexic focuses on medications designed 
to induce weight gain such as antidepressants, lithium, and anticonvulsants. Treatment 
trials with this methodology are not proven to have long-term efficacy. Use of SSRIs in 
the treatment of acute anorexia also has limited results. Attia and Schroeder (2005) 
reported no benefit of fluoxetine use in inpatient anorexics as compared to placebo. They 
hypothesized that underweight anorexics may have neurochemical disturbances 
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disrupting the drugs' mechanism of action, specifically disturbed 5-HT function. 
Problematically for this hypothesis, 5-HT disturbance appears to remain in anorexic 
individuals even after recovery (Kaye et al., 2005). The purported inaction of SSRIs on 
the acute anorexic may be caused by an unknown mediating factor, perhaps the body’s 
physical state. Interestingly, fluoxetine is reported as effective in weight maintenance as 
it is in weight restoration, although results are still inconclusive (Kaye et al., 1999).  
Numerous other medications are used to induce weight gain in the anorexic 
individual. The opiate antagonists naloxone and naltrexone both result in consistent 
weight gain in underweight anorexics. A randomized, placebo-controlled, double-blind 
study on anorexics using naltrexone similarly reported significant improvement in eating-
disordered behaviors such as binge-eating and purging (Marrazzi, 1995). These findings 
offer further support for the autoaddiction opioid theory of anorexia and should prompt 
future investigation into an addiction model of anorexia. A small study of lithium 
reported short-term weight gain in an anorexic population, but additional research is 
needed (Gross, Ebert, Faden, et al., 1981). Because of its appetite-stimulating effects, 
THC was examined in an anorexic population. No benefit of weight gain was seen, and 
several participants dropped out of the study due to the side effects of the THC such as 
paranoia, interpersonal sensitivity, and sleep disturbance (Gross, Ebert, Faden, et al., 
1983). Use of THC is this population was not shown to be efficacious.  
Finally, antipsychotics have been heavily examined in the anorexic population 
with studies dating as far back as the 1960s. Initial studies did show enhanced weight 
gain, particularly on chlorpromazine, but participants displayed negative side effects such 
as seizures and increased purging (Attia & Schroeder, 2005). Pimozide was also 
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examined in an anorexic population, and although it did result in weight gain, there was 
no improvement in patient behaviors or attitudes. Due to the significant negative side 
effects and the minimal clinical efficacy of the traditional antipsychotics, they have not 
been considered for mainstream anorexic treatment. The new atypical antipsychotics 
present a new option for eating disorder clinicians due to their more manageable side 
effects. In particular, olanzapine has been examined in several studies. It is currently 
associated with some behavioral and psychological improvement as well as improved 
weight gain (La Vie, Kaye, & Grey, 2000; Powers, Santana, & Bannon, 2002). Clinical 
trials are needed to further support the efficacy of this medication for anorexia.  
Most treatment practitioners working in the field of eating disorders recognize the 
benefit of a combined pharmacotherapeutic and psychotherapeutic approach to treating 
these multifaceted disorders. A review completed by Shapiro and colleagues (2007) 
found only six studies examining the combined effects of pharmacotherapy and 
psychotherapy in the treatment of bulimia. Combined treatment was associated with a 
greater decrease in both binge and purge behaviors (Goldbloom, Olsted, Davis, et al., 
1997; Walsh, Wilson, Loeb, et al., 1997). Combined treatment studies for anorexia are 
few and far between, with neither pharmacotherapy nor psychotherapy showing 
consistent positive outcomes. The numerous factors neurologically, socially, culturally, 
cognitively, and biologically account for the difficulty in finding successful treatment 
strategies for both bulimia and anorexia. To date, a myriad of different approaches are 
used psychotherapeutically to treat these disorders.  
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Psychotherapeutic Models for the Treatment of Eating Disorders  
Seven primary treatment models for eating disorders are commonly used today. 
They are (a) psychodynamic therapy, (b) cognitive behavioral therapy (CBT), (c) 
enhanced cognitive behavioral therapy (eCBT), (d) integrative cognitive-affective 
therapy (ICAT), (e) interpersonal therapy (IPT), (f) dialectical behavioral therapy (DBT), 
and (g) the addiction model.  
Psychodynamic psychotherapy is one of the oldest and most respected forms of 
treatment for mental illness. The psychodynamic philosophy places emphasis on internal 
conflicts and motives as well as unconscious forces. Through this focus on unconscious 
motives and conflicts, therapists are able to help the patient decipher the root causes of 
their behaviors (Trull & Phares, 2001). While there are numerous psychodynamic 
theories, such as self psychology and object relations, the underlying core concept of 
treatment does not vary significantly. The underlying approach of psychodynamic 
therapies is that underlying causes for disordered behaviors must be addressed and 
resolved or else the behavior will continue to return. While traditional psychodynamic 
views of maladaptive food behaviors were fixated on the sexual nature and interpretation 
of the individual’s relationship to food, modern psychodynamic practitioners in the field 
of eating disorders have a distinctly different view of maladaptive food behaviors 
(Furumoto & Keating, 1995).  
Modern psychodynamic theorists posit that adaptive behaviors arise when 
developmental needs are not met (Costin, 1999). Adaptive behaviors then function as 
substitutes for the developmental deficits and protect the individual against resulting pain, 
frustration, and/or anger. The primary difficulty with these adaptive behaviors is that they 
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never become internalized, as they do not have the ability to replace the behaviors needed 
for healthy development. For individuals struggling with eating disorders, some of these 
adaptive behaviors can go on to threaten long-term health and may even lead to death. 
For example, an individual who was never taught to self-soothe may rely on food for 
comfort and thus binge eat when distressed. Another common example is an individual 
who never developed an internal locus of control. When all control in the individual’s life 
is externalized, events may feel chaotic, and severe restriction and control of food may 
provide an internal sense of stability and safety. Gabbard (2000) provided a 
comprehensive summary of the multiple developmental deficits that an individual may 
experience and how eating-disordered behavior may serve as adaptive behavior:  
 
(1) a desperate attempt to be special, (2) an attack on the false sense of self 
fostered by parental expectations, (3) an assertion of a nascent true self, (4) an 
attack on a hostile maternal introjects viewed as equivalent to the body, (5) a 
defense against greed and desire, (6) an effort to make others—rather than the 
patient—feel greedy and helpless, (7) a defensive attempt to prevent 
unmetabolized projections from the parents from entering the patient, and (8) an 
escalating cry for help to shake the parents out of their self-absorption and make 
them aware of the child’s suffering.  
 
 
In the psychodynamic framework, symptoms are considered to be expressions of a 
struggling inner self. For an individual with an eating disorder, this struggling inner self 
is using the disordered eating and weight-control behaviors as the primary method of 
expressing the underlying problems or issues. These symptoms, then, are actually the 
only method of communication for the pain and anger that the individual has, and thus 
efforts to take them away are avoided (Costin, 1999). Ultimately, once the individual has 
learned to internally meet his or her needs and no longer struggles with his or her initial 
39 
development deficits, the eating-disordered behaviors will no longer be necessary and 
will subside on their own.  
Regardless of the primary framework of the psychodynamic approach, the 
primary goal in therapy is to help the patient gain insight into how his or her past, 
personality, and personal relationships interact and how this interaction relates to the 
eating disorder. While an understanding of these factors and their interplay is clearly 
valuable to an individual with an eating disorder, the psychodynamic approach to treating 
eating disorders has two problems. First, patients with eating disorders are often in such a 
state of depression, starvation, and/or compulsivity that their ability to explore their 
histories and interpersonal relationships is almost nonexistent. In consideration of this, 
medical stability, suicidal tendencies, starvation, compulsive binging/purging, and other 
harmful behaviors will have to be addressed before any psychodynamic work can 
commence (Costin, 1999). Second, it may take years for the patient to come to a full 
understanding and integration of the factors leading up to his or her eating disorder. 
During this time, the individual’s harmful behaviors may persist or worsen. This second 
concern calls for an intervention with more immediate benefits.  
Cognitive behavioral therapy (CBT) is recognized as the most efficacious form of 
treatment for bulimia and is often referred to as the Gold Standard (Fairburn, 2006). 
Recently, the National Institute for Clinical Excellence (NICE) assigned CBT a grade of 
A as an empirically supported treatment modality for bulimia. Despite these accolades, 
40% of individuals with bulimia who complete CBT will have relapsed by a 60-week 
follow-up (Fairburn, Cooper, Doll, O’Connor, Bohn, & Hawker, 2008). The primary 
mechanism of action in CBT is to help the client identify and change maladaptive 
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cognitions. Cognition is a mental perception or awareness of one’s world. Cognitions are 
fundamental to an individual’s ability to navigate the world in a successful manner. They 
provide algorithms and patterns that make sense of the overwhelming sensory experience 
of daily life. Individuals who struggle with depression, low self-esteem, anxiety, and a 
myriad of other life-disrupting conditions typically struggle with harmful, or maladaptive, 
cognitions.  
Individuals who struggle with eating disorders tend to have rather insidious 
cognitions concerning their identity, body, food, and other concepts tied to the inception 
and maintenance of an eating disorder. These maladaptive cognitions are held sacred 
because they provide a sense of control and order to an otherwise chaotic universe 
(Costin, 1999). Eating-disordered behaviors such as binge eating, food restriction, 
purging, and overexercising are all products of beliefs, attitudes, and assumptions about 
the meaning of body weight and eating. These beliefs, attitudes, and assumptions are 
typically distorted and in extreme situations may lead to an eating disorder. One of the 
primary jobs of a therapist, regardless of orientation, is to begin to address, challenge, and 
change these disordered thought processes. As mentioned previously, this is the primary 
mechanism of action for a CBT therapist.  
Costin (1999) identified four primary functions that cognitive distortions serve for 
an individual suffering from an eating disorder.  
1. Cognitive distortions provide a sense of being in control and being safe.  
Example: Cognitive distortions such as all-or-nothing thinking and extreme thinking 
provide a strict system of rules concerning acceptable and forbidden foods. Costin 
discussed one bulimic woman who allowed herself no fat in her diet. If she did 
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happen to eat something with fat in it, then she felt as though she had “failed her 
system” and would subsequently binge on all of the forbidden foods and then purge.  
2. Cognitive distortions further reinforce the eating disorder as an integral part of the 
person’s identity.  
Example: Eating-disordered behaviors such as restriction, overexercising, and weight 
issues make the person feel unique and special. The individual becomes identified to 
others as an individual with an eating disorder and further internalizes this 
identification until the individual does not know who he or she would be without the 
eating disorder. The maladaptive thoughts and beliefs create the individual’s sense of 
self.  
3. Cognitive distortions enable the individual to replace reality with a system that 
supports the individual and allows him or her to rationalize his or her behaviors.  
Example: Individuals struggling with an eating disorder use their distorted system of 
rules to create a safe world to navigate. Magically thinking that one’s worries will 
disappear as long as one weighs only 78 pounds creates a system where the individual 
focuses solely on obtaining the goal weight at the cost of any other indicators of 
reality.  
4. Cognitive distortions help provide a justification or explanation of the individual’s 
behaviors to other people.  
Example: Physiological maladies are often drawn upon as explanations as to why an 
individual can’t and/or won’t eat. Allergies pertaining to sugar, dairy, wheat, and 
other common ingredients are often created to explain an individual’s severe 
restriction from a certain food group. Statements such as “I already ate” are meant to 
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soothe concerned family and friends. For an individual struggling with an eating 
disorder, “eating a meal” can be equivalent to eating a small handful of grapes or a 
cup of air-popped popcorn.  
As shown, cognitive distortions provide an insidious mechanism for the eating 
disorder to infiltrate the core of a person’s sense of self. If these distortions are not 
appropriately addressed, the distortions and the corresponding symptomatic behaviors 
will persist.  
Despite the reported therapeutic efficacy of these primary types of treatment for 
eating disorders, they still result in disappointingly low rates of total remission. There are 
only two major studies examining the efficacy of CBT. Rates of recovery stall around 
40%. In a large study funded by the National Institute of Mental Health, recovery rates in 
the intervention sample were 40% while the treatment-as-usual group saw recovery rates 
of 29% (Agras et al., 2000). The McKnight Foundation found a recovery rate of 41% in 
the intervention sample and 31% in the treatment-as-usual group (Mitchell, Halmi, 
Wilson, Agras, Kraemer, et al., 2000). Due to the low rates of recovery, newer forms of 
therapy are constantly being investigated for the treatment of eating disorders.  
Fairburn, Cooper, and Shafran (2003) recently developed a form of CBT 
specifically designed to treat individuals with eating disorders. This form of therapy, 
called enhanced CBT (eCBT), includes the core premises of CBT while adding four 
additional factors specific to the eating-disordered population. eCBT places a special 
emphasis on interpersonal difficulties, clinical perfectionism, mood intolerance, and low 
self-esteem. This form of treatment was designed for outpatient therapy and has two 
treatment models. One is for an eating disorder patient with a BMI greater than 17.5; it 
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takes 20 weeks to complete the entire sequence. The second sequence is for individuals 
with a BMI lower than 17.5 and takes 40 weeks to complete. Fairborn et al. (2003) 
devised a complete treatment strategy around four stages. The first stage incorporates 
case formulation with early behavioral change. This stage is designed around biweekly 
treatment sessions. The second stage reviews the case formulation and incorporates a 
more in-depth intervention for the individual's problems in areas specific to the four 
factors listed above. Stage 3 contains the majority of the treatment utilizing CBT 
concepts but also includes modules specific to the four factors. Finally, during Stage 4, 
the therapist works to help the individual devise a relapse prevention plan and encourage 
the continuation of recovery. Results on the efficacy of eCBT are not yet available, as 
Fairborn and colleagues are currently involved in a large study.  
Another variation of the CBT paradigm is integrative cognitive-affective therapy 
(Mitchell, Agras, & Wonderlich, 2007). This form of therapy emphasizes self-oriented 
cognitions, interpersonal schemas, emotional experiences, interpersonal patterns, and 
cultural experiences. Integrative cognitive-affective therapy is strongly based in 
personality, attachment, and self-discrepancy theories. The theoretical background of this 
theory is that individuals who suffer from bulimia experience a self-deficit between their 
actual self and their ideal self. Due to this deficit, they develop an internal aversion to 
their sense of self and corresponding negative affect. As they expect to be rejected for not 
living up to the expectations of others, they develop maladaptive interpersonal patterns to 
stave off abandonment and/or rejection. Similar to eCBT, this intervention is 
conceptualized in four distinct phases. The first phase incorporates the first three sessions 
of therapy. During this phase, the therapist focuses on increasing client motivation and 
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psychoeducation. The second phase occurs over the next five sessions of therapy and is 
focused on normalizing eating behaviors and helping the client develop coping skills. 
Phase 3 spans Sessions 9 to 18 and contains the bulk of the work concerning 
intrapersonal (cognitive) and interpersonal factors. In Phase 3, the therapist and client 
focus on the primary factors, mentioned above, that make up the bulimic individual’s 
pathology. Finally, Phase 4 focuses on the development of a maintenance and relapse 
prevention plan.  
Another primary form of therapy used to treat bulimia is interpersonal therapy 
(IPT). IPT is based on the premise that interpersonal factors play a significant role in the 
inception and maintenance of many disorders. It was originally developed as an 
intervention for depression (Weissman & Markowitz, 1995). IPT for bulimia focuses on 
four areas of interpersonal concern: interpersonal role disputes, interpersonal deficits, role 
transitions, and grief (Jacobs, Robinson-Welch, & Wilfley, 2004). Typically, IPT engages 
several therapeutic tools used to address these four areas, which include but are not 
limited to communication training, feedback on problematic interactive patterns, 
identification and exploration of feelings, and expectation modification. To date, IPT is 
the only form of therapy that has outcomes comparable to those of CBT (Agras, Walsh, 
Fairburn, Wilson, & Kraemer, 2000; Fairburn, Jones, Preveler, Hope, and O’Connor, 
1993). Research suggests that this type of therapy may take longer to have an effect, as 
end-of-treatment assessments are less favorable than those of CBT. Interestingly, at 1-
year follow-ups, the differences between individuals treated with CBT, as compared to 
those treated with IPT, are insignificant. IPT therefore presents as a viable treatment 
alternative for individuals with bulimia who are reluctant to engage in CBT or are 
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struggling with interpersonal problems.  
Dialectical behavioral therapy (DBT), pioneered by Marsha Linehan, has become 
popular as a treatment choice for those struggling with an eating disorder. DBT was 
originally designed to treat individuals suffering from borderline personality disorder 
and/or struggling with suicidal and self-injurious behaviors (Linehan, 1993). The 
methodology of DBT has since been modified for use in the treatment of eating disorders 
and was shown to be effective in a small study conducted by Safer, Telch, and Agras 
(2001). The treatment focus in DBT is behavioral change and strategies to help 
individuals learn to accept themselves. The intervention is focused on the relationship 
between the change process and self-acceptance. Linehan developed four skill modules 
involved in skill acquisition: mindfulness, interpersonal effectiveness, emotion 
regulation, and distress tolerance. Researchers hypothesize that DBT is effective in 
treating bulimia because it targets the individual’s problems with emotion dysregulation, 
which may be one of the core factors underlying bulimia (Mitchell et al., 2007).  
Finally, some eating disorder practitioners use an addiction or disease model to 
treat eating disorders. This model is also known as the abstinence model. This model is 
adapted from the disease model of alcoholism (Rosenberg, Devine, & Rothrock, 1995; 
Rosenberg & Rosen, 1994; Weisner, 1995). In this model, alcoholics are considered 
powerless because the disease of alcoholism creates abnormal and addictive responses in 
their body to the consumption of alcohol. Because of these abnormal and addictive 
responses, the individual considers him- or herself to be powerless over the alcohol and 
turns to a greater “power” for help. The Twelve Step program of Alcoholics Anonymous 
was designed around this principle and is used worldwide to treat alcoholism. When 
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practitioners apply this model to the treatment of eating disorders, they simply replace the 
word “alcohol” with “eating disorder,” resulting in addiction support groups such 
as Eating Disorders Anonymous (EDA) and, similarly, Overeaters Anonymous (OA). 
The primary treatment approach of EDA and OA is to help the participant create and 
maintain abstinence from foods that are considered to have addictive qualities, such as 
sugar and white flour. As the participants work to gain and maintain abstinence from 
these addictive foods, they work through the Twelve Steps of EDA.  
The initial application of the addiction analogy of alcoholism to compulsive 
overeating stems from the idea that if ingredients in alcohol could lead to an addictive 
state, then certain foods might have the same effect. Despite the large numbers of 
individuals utilizing the twelve-step model to help overcome their harmful relationship 
with food, there is also no proof that the addiction model is a successful treatment model 
for eating disorders or compulsive overeating (Costin, 1999). According to Hatsukami, 
Owen, Pyle, and Mitchell (1982), the addiction model for the treatment of eating 
disorders appears to have been readily adopted by practitioners due to the absolute dearth 
of other treatment models. In 1993, the American Psychiatric Association (APA) 
cautioned against the use of twelve-step models as the primary treatment for bulimia and 
anorexia in their treatment guidelines for eating disorders. The APA stated concerns that 
due to  
 
the great variability of knowledge, attitudes, beliefs, and practices from chapter to 
chapter and from sponsor to sponsor regarding eating disorders and their medical 
and psychotherapeutic treatment and because of the great variability of patients’ 
personality structures, clinical conditions, and susceptibility to potentially counter 
therapeutic practices, clinicians should carefully monitor patients’ experiences 
with the Twelve Step programs. (APA, 1993)  
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Psychotherapeutic Treatment Outcomes in Bulimia   
In order to fully conceptualize the purpose and use of different treatment 
modalities, it is important to define what recovery from bulimia is and the goal for 
intervention. Typically, there are six primary objectives in the successful treatment of 
bulimia (Mitchell et al., 2007). The first goal is to eliminate binge eating patterns and 
compensatory behaviors. Second, the goal is to help the individual return to a normal and 
healthy pattern of eating. Third, the importance of medical stability is taken into 
consideration, and physical complications from the disorder are assessed. The fourth 
objective is to address the underlying psychological concerns of the individual. This 
typically includes addressing issues with self-esteem, interpersonal concerns, body image 
dissatisfaction, and any other dysfunctional thought or behavioral patterns. Finally, 
treatment must take into consideration comorbid conditions and address them effectively. 
For example, it is quite common for individuals suffering from bulimia to have comorbid 
diagnoses of depression and anxiety. The final objective of the treatment of bulimia is to 
prevent relapse.  
Literature on treatment modalities for bulimia is widespread. Since its original 
description in 1979, a breadth of information regarding this disorder has developed. 
Mitchell, Agras, and Wonderlich (2007) noted six main treatment modalities for bulimia 
that are commonly used to treat this disorder. The first of these interventions has already 
been discussed at length—psychopharmaceuticals. Optimal treatment results are seen 
where there is a combination of psychopharmaceuticals and some form of psychotherapy. 
The other five primary forms of treatment intervention for bulimia  have already been 
discussed. They are (a) cognitive behavioral therapy (CBT), (b) enhanced cognitive 
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behavioral therapy (eCBT), (c) integrative cognitive-affective therapy (ICAT), (d) 
interpersonal therapy (IPT), and (e) dialectical behavioral therapy (DBT).  
Fairburn, Agras, Walsh, Wilson, and Stice (2004) found that the best predictor of 
a good outcome at 8 months follow-up from treatment was an early reduction in purging 
behavior. Unfortunately, there have been no studies supporting this as a positive outcome 
variable 8 months posttreatment. Other researchers indicate that normalization in eating 
patterns is a positive outcome predictor at 3 months posttreatment (Burton & Stice, 
2006), but again there are no longer term follow-ups available. Clearly, while many 
variables are hypothesized concerning the inception of, maintenance of, and recovery 
from bulimia, none of these variables have been clearly indicated through research.  
While a wide range of treatment strategies for bulimia exist, the effectiveness of 
such strategies is low. Wilson (1996) and Agras (1993) maintained that recovery is only 
achieved by about 50% of patients who enter treatment. Such low numbers prove that 
further investigation into existing methods is needed. Complications with treatment are 
often related to the difficulty in defining the etiology of eating disorders as well as the 
role of societal and cultural factors. Researchers appear to have reached a consensus 
regarding the importance of cognitions and interpersonal relationships in the maintenance 
of bulimia. However, many clinicians and researchers also report reaching an impasse 
when trying to identify which forms of therapy are most appropriate for each individual. 
For example, Nevonen and Broberg (2006) suggested that IPT is more effective with 
bulimic individuals struggling with impulsivity and affective instability, whereas CBT is 
the treatment of choice for those whose EDO has an origin in body image, eating 
concerns, and a focus on weight.  
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Unfortunately, these aspects of an individual’s eating disorder may not emerge 
until late in treatment. A recent factor analysis examining commonly used treatment 
strategies for eating disorders reported that only 6% of respondents used a standardized 
treatment manual, while 98% of the respondents used an eclectic methodology combining 
strategies of all seven treatment methods described above (Tobin, Banker, Weisberg, & 
Bowers, 2007). Empirically validated outcome strategies are almost impossible to assess 
in such a varied and diverse treatment arena. Thus far, current research has only focused 
on outcome data, which merely highlight success or failure in treatment.  
 
Psychotherapeutic Treatment Outcomes in Anorexia   
The treatment of anorexia suffers from much darker outcome results than bulimia. 
Longitudinal studies on anorexia report high mortality rates. Studies with follow-ups 
completed 5 to 10 years after treatment report mortality rates of 3% to 6%, range 0% to 
11.5%, while studies with a longer period between treatment and follow-up portray an 
even grimmer picture, with mortality rates between 0% and 17.5% (Fichter, Quadflieg, & 
Hedlund, 2006). Several studies have attempted to establish outcome predictors. 
Following regression analysis, 11 variables predictive of outcome appear to be similar 
across studies: duration of the eating disorder, age of onset, family of origin, age at onset 
of menstruation, sexual problems, psychiatric comorbidity, perfectionism, impulsivity, 
self-evaluation, extroversion, and low body weight (Fairburn, Cooper, Doll, & Welch, 
1999; Keel & Mitchell, 1997; Lindberg & Hjern, 2003; Quadflieg & Fichter, 2003; 
Steinhausen, 2002). These predictive variables may present in a wide variety of 
constellations. Other problems with the development of effective and empirically based 
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treatments for anorexia include the small sample sizes of the studies and their contrasting 
results. 
A recent investigation by Fichter, Quadflieg, and Hedlund (2006) followed 103 
individuals for 12 years who were admitted for the treatment of anorexia. Follow-ups 
were conducted at 2, 6, and 12 years posttreatment. The investigation of Fichter et al. 
(2006) provided important results due to the long-term follow-up and large sample size. 
The results of this study were illuminating and shed light on a series of factors that ought 
to be incorporated into the successful treatment of anorexia. These variables, shown in 
Table 1, exemplify factors consistent across a large sample size.  
The greatest predictor of poor outcome for anorexia is sexual problems. This 
variable includes body contact, sexual arousal, and related feelings. Two 
conceptualizations are obvious when discussing the role of this variable in the 
maintenance of anorexia. Sexual problems may relate to factors involving maturation, 
self-identity, self-esteem, as well as societal conceptualizations of the sexualized female 
form. This variable highlights the possible interaction of sexual abuse and lingering 
intimacy concerns in the maintenance of anorexia. Participants in this study who had 
experienced sexual abuse before the age of 11 had significantly higher sexual problems 
and poorer outcome rates. This demonstrates the importance of treating sexual problems 
in individuals struggling with anorexia. The second primary predictor of poor outcome of 
treatment in individuals with anorexia was impulsivity, also a commonly accepted 
predictor of bulimia. The last two significantly predictive variables were duration of 
inpatient stay and duration of eating disorder. The more time an individual spent in an 
inpatient setting, the worse his or her prognosis became. Similarly, the longer an  
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Table 1 
Final Predictive Model of Poor Eating Disorder Outcome 12 Years After Index 
Treatment in Anorexia Nervosa (Fichter et al., 2006) 
 R2 = 0.45 predictor Wald statistics Odds ratio 95% CI 
1 High intensity of sexual problems 6.9** 5.08 1.51–17.09
2 Impulsivity 4.9* 3.71 1.16–11.87
3 Long duration of index inpatient treatment 4.2* 1.52 1.02–2.28 
4 Long duration of eating disorder 9.7** 1.27 1.09–1.47 
Note. 95% CI = 95% confidence interval. 
* p < .05. 
**p < .01. 
 
 
individual suffered from anorexia, the greater his or her chances were of achieving a poor 
outcome. 
While the predictors found in the investigation of Fichter et al. (2006) are 
important, Fichter et al. also reported interesting results regarding individuals in 
remission from anorexia. The typically accepted definition for recovery from anorexia, 
weight being within 15% of ideal body weight (le Grange & Rock, 2005), may not be an 
adequate predictor of eating disorder remission or recovery. Despite no longer meeting 
the diagnostic criteria for anorexia, these individuals still maintain significantly different 
characteristics from the normal population. For example, recovered individuals 
maintained significantly higher levels of eating-disordered behaviors and general 
psychopathology. Recovered anorexics also maintained certain pathological attitudes in 
regard to the thin ideal and body image. Interestingly enough, there was no difference 
between non-eating disordered women and the recovered individuals in regard to eating-
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disordered characteristics related to binge eating, atypical compensatory behaviors, or 
restrictive eating patterns. These results further highlight the difficulty in treating body 
image disturbance despite an alleviation of food-related eating disordered behaviors. Le 
Grange and Lock (2005) completed a review of all literature reporting on therapeutic 
treatments and/or efficacy for anorexia. They identified eight uncontrolled and five 
controlled studies examining the treatment of adolescents with anorexia, and seven 
controlled investigations on the treatment of adults with anorexia. There is clearly a 
dearth of literature and research examining the treatment of this life-threatening disorder.  
In 1975, Minuchin and associates completed what is now considered a seminal 
work for the treatment of adolescents with anorexia. In an uncontrolled investigation at 
the Child Guidance Clinic in Philadelphia, PA, they treated 53 adolescent patients with 
family therapy and wrote an article discussing their results (Minuchin, Baker, Rosman, 
Liebman, Milman, & Todd, 1975; Minuchin, Rosman, & Baker, 1978). The individuals 
in this study were largely comprised of adolescents (only 3 were greater than 18 years of 
age) diagnosed with anorexia for 8 months or less. Minuchin and associates reported very 
high success rates. Eighty-six percent of the patients were reported recovered at the time 
of follow-up. While the results appear very promising, it is important to remember that 
duration of illness is most likely a primary predictor of outcome and that the short 
duration of the illness might have positively impacted recovery rates. Regardless, the 
work of Minuchin and his associates was impactful for two reasons: (a) the number of 
recovered individuals was large, and (b) the theoretical underpinnings of their approach 
could be replicated.  
Minuchin and associates (1975) conceptualized a “psychosomatic family” that 
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was at the core of an individual’s struggle with anorexia. The “psychosomatic family” 
consisted of a particular family process in which family members were enmeshed, rigid, 
and highly avoidant of conflict. This family system sets the stage for an individual, when 
coupled with the developmental demands of adolescence, to develop anorexia as a way of 
navigating the system. Minuchin and associates (1975) cautioned against seeing their 
theory as an etiologic concept of how anorexia develops, urging readers instead to 
consider the eating disorder within this framework as a constantly shifting and evolving 
part of the family process. Therefore, the ultimate goal of the Minuchin treatment was to 
alter the family’s interactive engagement.  
It wasn’t until 1987 that a group of researchers at the Maudsley Hospital in 
London attempted a systematic investigation of the Minuchin methodology. Russell, 
Szmukler, Dare, and Eisler (1987) examined the effectiveness of individual outpatient 
therapy as compared to family therapy in adolescents with anorexia. While Russell and 
associates largely recreated the environment of Minuchin’s treatment, they added in 
several new key variables. For example, they engaged the parents in the refeeding 
process of the adolescents and maintained parental involvement in this matter until 
weight was restored. They also did not begin to address individual or family concerns 
until after weight restoration was achieved. Russell et al. (1987) compared family therapy 
to a systematized supportive individual therapy conceptualized as “treatment as usual.” 
Results of these studies showed promise for the method conceptualized by Minuchin and 
associates (1975). At the 5-year follow-up, only 36% of patients who received individual 
therapy reported a favorable outcome, whereas 90% who received family therapy had a 
positive outcome.  
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More recently, other investigators have compared different forms of family 
therapy for the treatment of adolescent anorexia. These studies found that regardless of 
the type of family therapy (conjoint family therapy vs. separated family therapy), 
individuals receiving family therapy still had significantly better outcome results than did 
those just receiving individual therapy (Eisler, Dare, Hodes, Russell, Dodge, & Le 
Grange, 2000; Morgan & Hayward, 1988). Eisler et al. (2000) also found results for 
families and individuals who participated in conjoint family therapy. At 5-year follow-up, 
75% of patients who received some form of family therapy had a positive outcome, as 
compared to 15% who had good outcomes with individual therapy. Another study 
investigated outcomes with behavioral systems family therapy as compared to ego-
oriented individual therapy (Robin, Siegel, Moye, Gilroy, Dennis, & Sikand, 1999). 
Robin and associates found that individuals who received family therapy were 
significantly more likely to return to normal weight and to have regained their menses. 
Interestingly, the two groups showed no difference in regard to changes in depression, 
eating attitudes, and eating-related family conflict. These results emphasize the potential 
role of the family in the physical aspect of recovery but not in the more cognitively 
oriented aspects of recovery. This is an essential differentiation, as almost all studies, to 
date, have defined an individual as recovered from anorexia if he or she has returned to 
normal weight. 
In comparison to studies examining adolescents with anorexia, studies examining 
interventions for adult individuals with anorexia are just as difficult to find. Before le 
Grange and Lock’s review (2005) of the treatment of anorexia, there had only been seven 
studies examining outpatient therapy outcomes of individuals with anorexia. These 
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studies examined a variety of therapies such as individual therapy, cognitive behavioral 
therapy, individual therapy combined with family therapy, group therapy, dietary 
counseling, and nutritional advice. Similar to the studies on individuals with bulimia and 
adolescents with anorexia, all outcome results were based on posttreatment reported 
results via either a self-report questionnaire or a clinical interview.  
In 1987, the first controlled trial investigating outpatient treatment results on 
adults with anorexia was published. Thirty-six patients were randomly assigned to 
receive either individual or family therapy following discharge from the hospital (Russell, 
Smuzkler, Dare, & Eisler, 1987). Although those who received individual therapy 
showed an initial improvement over those receiving family therapy at the 5-year 
mark, there was no significant difference between the two groups. Another study found 
similar results when examining two different types of individual therapy, focal therapy 
and cognitive analytic therapy, when compared to family therapy (Dare, Eisler, Russell, 
Treasure, & Dodge, 2001). No single form of therapy proved more efficacious than the 
others at the time of treatment termination. Numerous other studies investigating and 
comparing a variety of treatment modalities for anorexia have found similar results, with 
no significant difference between the groups at time of termination (Channon, De Silva, 
Hemsley, & Perkins, 1989; Crisp, Norton, Gowers, Halek, Bowyer et al., 1991; Treasure, 
Todd, Brolly, Tilley, Nehmed, et al., 1995).  
Only two studies examining controlled treatment effects on adults with anorexia 
had significant results. One study compared nutritional counseling to outpatient CBT in 
33 women posthospitalization (Pike, Walsh, Vitousek, Wilson, & Bauer, 2003). This 
investigation was more empirically sound than those previously noted because it utilized 
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manualized treatment interventions. It is also important to note that this investigation was 
significantly more intense than the previous studies and consisted of 50 treatment 
sessions over a course of 12 months. Results of this study indicated a significantly lower 
nonresponse rate for individuals in the CBT group. Furthermore, when the researchers 
applied Fairburn and Cooper’s (1993) criteria of a good outcome –i.e., no binge eating or 
purging behaviors, weight restored, and < 1 standard deviation (SD) from the norm on the 
Eating Disorder Examination (EDE; Fairburn & Cooper, 1993), none of the individuals in 
the nutritional counseling group were shown to have a good outcome, while 17% of those 
in the CBT group did. While the results of this study are mildly discouraging, they 
portray the reality of current treatment outcomes for women struggling with anorexia.  
Another interesting study examined two of the specialized therapies purported to 
be the most efficacious for eating disorder treatment. McIntosh et al. (2005) examined the 
effectiveness of CBT and IPT compared to a treatment-as-usual group. Interestingly, after 
20 sessions for 20 weeks, the control treatment group had treatment outcomes that were 
superior to those of either CBT or IPT. The results of this study, as well as the previously 
discussed studies, indicate the difficulty in creating and implementing an effective 
treatment strategy for anorexia. These studies reported results of “good” and 
“intermediate” outcomes as anywhere from 29% to 63%, with the majority of individuals 
falling into the 60% range. It is also extremely important to remember that in all but one 
study, there were no follow-up data. The previously discussed long-range follow-up data 
of 12 years posttreatment paint a much grimmer picture, with mortality rates of up to 
17.5% and only 52.4% of participants obtaining recovery (Fichter, Quadflieg, & 
Hedlund, 2006).  
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In an unprecedented investigation, Kordy and associates (2002) examined 422 
bulimic and 233 anorexic patients over the course of 2.5 years. Utilizing the Longitudinal 
Follow-up Evaluation, they attempted to establish operational definitions for partial and 
full remission, relapse, and recovery for individuals with anorexia and bulimia (Frank et 
al., 1991). Given the previously discussed difficulties with defining outcome in this 
population, their task was not an easy one.  
Utilizing the operational definitions provided in Table 2, the treatment progress of 
a total of 655 patients was assessed using the Kaplan-Meier Survival Analysis to 
determine the chances for remission or recovery as well as those for relapse or 
recurrence. Partial remission was the most commonly observed clinical phenomenon. 
Twenty percent of the anorexic patients and 30% of the bulimic patients had progressed 
to this stage of treatment at the time of entering the posttreatment stage. These 
proportions did increase through the posttreatment stage to 55% for anorexics and 60% 
for bulimics. Full remission or recovery was a significantly rarer occurrence (Figure 4), 
with only 7% of anorexics and 18% of bulimics achieving full remission. Only 6% of 
anorexics and 16% of bulimics were considered recovered (Figure 5).  
Kordy and associates' (2002) research pinpointed important findings about the 
stability of remission and recovery in these disorders. Full remission and recovery was 
more stable than partial remission. Out of the 22 anorexic patients who obtained full 
remission or recovery during the 2.5 years of observation, only 2 relapsed (1 in Month 6 
and 1 in Month 21). Partial remission was much less stable, with 35% of the anorexic 
patients obtaining partial remission relapsing. During the first 7 months of achieving  
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Table 2 
Kordy and Associates (2002) Operational Definitions of Possible Eating Disorder 
Treatment Outcomes 
 Concept 
Symptom Partial Remission 
(1 month) 
Full Remission 
(3 months) 
Recovery 
(12 months) 
Anorexia: 
Restricting Type 
   
Underweight 
(kg/m2) 
BMI > 17.5 BMI > 19 BMI > 19 
Fear to gain weight -- No extremes No extremes 
Weight reduction by 
(#/wk) 
Vom.a & Laxb. = 0 Vom. & Lax. = 0 Vom. & Lax. = 0 
Binges (#/wk) 0 0 0 
    
Anorexia: Binge 
Purge Type 
   
Underweight 
(kg/m2) 
BMI>17.5 BMI>19 BMI>19 
Fear to gain weight -- No extremes No extremes 
Binges (#/wk) ≤ 1 0 0 
Weight reduction by 
(#/wk) 
Vom. & Lax. = 0 Vom. & Lax. = 0 Vom. & Lax. = 0 
    
Bulimia    
Binge/Purge (#/wk) ≤ 1 0 0 
Preoccupation with 
figure 
-- No extremes No extremes 
Weight reduction by 
(#/wk) 
Vom. & Lax. ≤ 0 Vom. & Lax. = 0 Vom. & Lax. = 0 
 
Relapse: change from partial or full remission to full syndrome according to DSM-IV 
Recurrence: change from recovery to full syndrome according to DSM-IV  
 
a Weight reduction by vomiting 
b Weight reduction by laxative abuse 
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Figure 4. Graphical Representation of Partial Remission in Eating 
Disorder Treatment (Kordy et al., 2002).  
 
 
 
Figure 5. Graphical Representation of Full Remission in Eating 
Disorder Treatment (Kordy et al., 2002). 
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partial remission, the risk of relapse for these patients was 5 times higher, with risk rates 
steadily decreasing after this period. Bulimic participants showed no significant 
differences between relapse risk for partial/full remission and recovery. Interestingly, 
patients in full remission or recovery were significantly more vulnerable to relapse during 
Months 4 through 6 of their remission-recovery period. After the 6-month mark, risk of 
relapse decreased dramatically. Of those who obtained partial remission at the 
posttreatment stage, only 40% maintained this state, with 60% relapsing. Up to the 6th 
month, the risk for relapse for partially remitted bulimics displayed similar relapse risk 
percentages as for the fully remitted/recovered patients.  
Kordy’s (2002) work was the first attempt to operationally define the treatment 
trajectory for this patient population. The results indicate the difficulty in treating these 
patients and the necessity for long-term care, significantly highlighting the most 
vulnerable stages of the treatment process. Clearly, treatment of these disorders is 
difficult and may at times seem impossible. With such a widely varied etiology, brain 
abnormalities lasting past recovery, and such a large variety of risk factors involved, how 
can a single treatment be successfully applied to all individuals struggling with this 
disorder? Each individual presenting with an eating disorder may, in actuality, be unique 
in etiology and symptom presentation of the eating disorder. The unfortunate outcome of 
this is that no treatment center or clinician will be able to apply a manualized treatment to 
all clients and expect strong outcome results.  
Dishearteningly, too many patients and clients slip through the cracks of eating-
disorder treatment due to the lack of knowledge and/or research regarding the efficacious 
treatment of their illness. One way to shed light on the highly varied presentations of 
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these disorders, and to prevent patients and clients from being treated by a therapeutic 
modality that does not address their concerns, is to monitor treatment progress throughout 
the treatment program. This review has examined numerous longitudinal studies for the 
treatment of eating disorders, and yet no single review was anything but either pre- 
and/or post-treatment. A continued mechanism of evaluation of treatment progress will 
increase the treatment provider’s ability to change treatment modalities should treatment 
progress not be ideal.  
 
 
Measuring Treatment Outcomes 
 
 In 1984, the World Health Organization implemented project “Health 2000,” 
committing member states to the development of measures to assess and assure quality 
health care services (World Health Organization, 2001). This initiative began a serious 
push toward the medical field’s focus on outcome measurements. As health management 
systems grew increasingly powerful and cost-effectiveness plans began to take priority, 
measures of health care quality, effectiveness, and treatment outcomes began to have 
serious social and political implications. Similarly, as consumers began to demand more 
transparency from the medical field, expectations of health care providers to provide 
empirically based results of reported successes also continued to rise. Today, while the 
numbers of outcome studies are still small, they are growing, driven by organizations as 
large as the National Institute of Mental Health and as small as private clinics seeking 
cost containment through ultimate efficiency.  
 Part of the increased focus on outcome measurements for psychotherapy stems 
from the realization that patient deterioration in psychotherapy is well documented, 
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although very little is known about the prevalence, rate, or magnitude of the deterioration. 
Some researchers posit that rates of deterioration are as low as 5% but may be as high as 
15% (Lambert & Bergin, 1994). The suggested rates of deterioration are not specific to 
any patient population, theoretical orientation, or treatment modality, and are even 
consistent in group and family therapies (Mohr, 1995; Shapiro & Shapiro, 1982; Smith, 
Glass, & Miller, 1980). Rates of deterioration have even been noted in groups that 
receive no treatment (Lambert, DeJulio, & Stein, 1978). The possibility of patient 
deterioration is a threat to all clinicians and needs to be more fully researched in order to 
provide effective client care. 
 
Outcome Research Modalities 
 The majority of treatment outcome research is designed as efficacy research. 
These investigations seek to minimize variance between external variables and maximize 
the control of internal variables. Through stringent methodologies, treatment effects are 
thus isolated and measurable. While efficacy research is accepted as the “Gold Standard” 
in this research arena (Kendall, 1998; Wells, 1999), results are typically not 
generalizable, given the strict controls implemented on treatment in the research 
environment.  Due to lack of generalizability noted in efficacy research, clinicians are 
starting to turn to the use of effectiveness research in order to measure and assess the 
success of various treatment modalities. Effectiveness research relies upon routine 
clinical practice to assess the real-world clinical success of different treatments. The 
focus here is on ecological validity rather than internal validity, such as that sought in 
efficacy treatment. This shift in focus allows clinicians and researchers to draw 
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generalizable conclusions about the success of different treatment modalities. In 
summary, efficacy research attempts to measure the potential success of a treatment in 
ideal treatment conditions. Effectiveness research examines how well a treatment works 
in a real-world setting (Howard, Moras, Brill, Martinovich, & Lutz, 1996). 
 While efficacy research and effectiveness research elucidate important aspects of 
treatment efficacy, they both focus solely on group response to treatment (Howard et al., 
1996), neglecting to maximize the effect of treatment being studied. In 2001, Lambert 
proposed the use of treatment outcome management procedures in order to improve 
treatment effects. Drawing upon the idea of patient-focused research (Howard et al., 
1996), Lambert suggested that treatment response should be measured continually, with 
feedback provided to clinicians in order to enable clinicians to track treatment and make 
treatment plan modifications as necessary. 
 Patient-focused research seeks to answer the most pressing question facing 
treatment providers: Is this patient responding to this treatment? To answer this question, 
Howard and associates (1986; 1993) utilized dose-response and phase models of 
treatment effectiveness to develop a method of patient profiling designed to provide 
continuous feedback on individual patient treatment responses. Data pertinent to 
treatment success are continuously collected and modeled on a graph. This data are then 
compared to an expected progress pattern developed for each patient based on clinical 
characteristics. Patient-focused research aids in the early identification of patients who 
are not responding to treatment at expected levels, allowing for alterations in the 
treatment plan in an effort to change the treatment outcome. Lambert, Hansen, and Finch 
(2001) stated three defining qualities for patient-focused research: (a) evaluates 
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individual patient progress over the course of treatment, (b) provides regular feedback to 
treatment providers, and (c) “attempts to answer the question, Is this particular treatment 
working for this patient?” (p. 159). 
 Efficacy, effectiveness, and patient-focused research are all valuable contributors 
to the wealth of research available concerning treatment outcomes. While the three are 
complementary procedures, there are distinct and important differences in their processes. 
Although efficacy and effectiveness research are widely recognized as the foundation of 
evidence-based practice, they are characterized by a top-down approach to patient care. 
Because of their methodology, they do not allow for the consideration of patients’ 
individual differences. Patient-focused care, on the other hand, presents a bottom-up 
approach to care that is driven by patient-specific information and geared toward 
enhancing patient outcomes. 
 
Patient-Focused Research Models 
To date, there are two primary patient-focused research models for measuring, or 
modeling, therapeutic outcome results: the Brigham Young University Model and the 
Stuttgart-Heidelberg Quality Assurance Model (Percevic, Lambert, & Kordy, 2004). The 
researchers at Brigham Young University have largely focused on predicting treatment 
failure. Their research has developed operational definitions for treatment success and 
treatment failure (Lambert & Finch, 1999; Wells, Burlingame, & Morrell, 2002). A main 
theoretical underpinning of the Brigham Young University model is that early treatment 
response predicts outcome and treatment nonresponse is indicative of treatment failure. 
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Therefore, through appropriate outcome measurements, clinicians can identify early 
nonresponders and change treatment accordingly.  
Utilizing a system developed by Lambert and associates to track patient progress 
session to session, clinicians are able to receive a large amount of data regarding their 
patients’ potential clinical outcomes. Lambert and colleagues engaged in a series of 
investigations analyzing the impact of feedback to clinicians on overall patient outcomes 
(Lambert, Whipple, Smart, Vermeersch, Nielsen, et al., 2001; Lambert, Whipple, 
Vermeersch, Smart, Hawksin, et al., 2002). These investigations found that feedback 
significantly improved the outcome of patients who were deteriorating in treatment or at 
risk for dropping out. Lambert and associates (2003) demonstrated that feedback on 
client outcomes, when provided regularly to clinicians, provides benefits that are not only 
substantial, but also replicable. One controlled investigation reduced patient deterioration 
rates to 13% in the clinician feedback group as compared to 21% in the treatment-as-
usual group. Improvement and recovery rates were similarly affected, improving to 35% 
in the feedback group from a baseline of 21%.  
 The Stuttgart-Heidelberg quality assurance model was developed in Germany at 
the Center of Psychotherapy and Research, Stuttgart. The model, similar to the Brigham 
Young model, began using continuous treatment outcome monitoring to develop a more 
thorough understanding of symptom course (Kordy, Hannöver, & Richard, 2001; Kordy 
& Lutz, 1995). The researchers found the symptom courses of their patients graphed as 
linear trends moving toward improvement. Each patient presented with independent 
change rates and significant residual fluctuation. Spitzer (2001) defined similar courses of 
treatment as “random walks.” The Stuttgart group adopted the random walk model as the 
66 
theoretical basis for the Stuttgart-Heidelberg quality assurance model.  
The primary benefit of outcome monitoring utilizing the random walk model is 
that it allows healthcare providers to integrate an adaptive allocation of therapeutic 
resources and a cost efficiency component to the treatment of their clientele. Through an 
assessment of current outcome and intended outcome, clinicians are able to provide 
appropriate treatment, i.e., they know when to terminate therapy for a client who is no 
longer suffering and know when to extend treatment to those who are not responding to 
treatment as expected. The Stuttgart model differs from the Brigham Young University 
model in that it does not rely upon prior data to assess whether the patient is responding 
as expected. Early nonresponse to treatment is not an indication of the patient’s overall 
outcome. Instead, the model focuses on the client in the “here and now,” assessing the 
presence of dysfunction throughout the course of therapy. The presence of dysfunction at 
any given point is indicative of further therapeutic intervention being necessary.  
Research supports the adaptation of therapeutic treatment time to match client 
distress. Percevic (2003) reported that utilizing the random walk model with continuous 
outcome monitoring, 85% of the experimental group achieved significant clinical 
improvement, as compared to 65% of the control group. In this same study, Percevic also 
examined therapy duration and found that with the appropriate allocation of therapeutic 
resources and monitoring, treatment duration could drop to as few as 19 sessions (down 
from 52) with the same levels of client improvement.  
Although relying on a different theoretical foundation, both feedback models 
clearly result in benefits to both clients and clinicians. Percevic and associates (2004) 
hypothesized that much of the benefit noted by clients is due to an “attention effect.” 
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Simply stated, therapists paid more attention to client progress when provided with 
continuous feedback about their client. Many theorists also apply the law of diminishing 
returns to therapy, believing that the more therapy one receives, the less effective it 
becomes over time, and that therapy may, if utilized for too long, actually become 
detrimental to the client (Howard, Kopta, Krause, & Orlinsky, 1986). Therefore, the 
appropriate allocation of therapeutic resources is similarly key in effective client care.  
 
Conclusion 
 With a reported treatment deterioration rate of 5% to 15% expected across all 
patient populations (Lambert & Bergin, 1984) combined with the notoriously difficulty in 
treating eating disorders, only 13% of anorexics and 34% of bulimics achieve full 
remission or recovery by the end of the posttreatment stage (Kordy et al., 2002). Accurate 
outcome treatment measures are crucial. The varied etiology and symptom presentation 
of these disorders make treatment extremely difficult. Patients respond in a variety of 
manners to different treatment paradigms as well as at different rates (Kordy, Haug, & 
Percevic, 2006), further enhancing the difficulty in providing effective patient care.  
Given the longstanding nature of an eating disorder, it is not unusual for a patient 
to progress through a variety of treatment stages as his or her treatment progresses. As 
patients work toward recovery, their treatment must be appropriately tailored to meet 
their needs. Again, one is reminded of the law of diminishing returns in therapy (Howard 
et al., 1986) as well as the importance of appropriate allocation of therapeutic resources. 
One of the most difficult aspects of treatment to assess is when it is the appropriate time 
to transition from one therapeutic modality to the next, be it higher or lower level care 
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(Kordy et al., 2006). A number of researchers have relied upon a theoretical backing 
similar to the Brigham Young model to assess patient outcomes and appropriate 
treatment transition points. For example, Agras and associates (2000) reported that 
patients who responded early to treatment had better outcomes than those who responded 
to treatment later. Outcome monitoring systems have been implemented with this 
ideology in mind, with an eye toward assessing when patients are not meeting treatment 
goals. This allows clinicians to plan interventions that inhibit patient deterioration or 
dropout.  
 Recently, Percevic and associates (2006) reported that symptom change across 
therapy was negatively correlated with immediate treatment responders making strong 
gains at first but then decreasing gains as therapy continued. Inversely, slow or non-
responders at the beginning of therapy were seen as making large treatment gains later in 
therapy. This has important implications for the treatment of eating disorders. Often, 
patients considered to be non-responders are moved to a higher level of care and quick 
responders are held to the standard course of therapy designed by the treatment program. 
Both of these actions have important implications for the successful allocation of 
therapeutic resources and the overall treatment of patients.  
 Current treatment for an eating disorder is designed to meet the standard 
demanded either by insurance companies or by treatment providers. As providers become 
more accustomed to a standardized treatment course, it is often easier to simply “go 
through the motions” with each new patient rather than assess patients for their individual 
treatment needs. If, however, as research has shown (Agras et al., 2001), patients do 
respond to treatment at a variety of speeds and levels, then treatment does need to be 
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tailored to match each patient, allowing for the most effective use of therapeutic 
resources and the most beneficial client care. Kordy and associates (2006) called this type 
of treatment Individually Tailored Service Allocation.  
 Individually tailored service allocation implies that treatment outcomes cannot be 
known from the beginning of intake; instead, treatment must be consistently monitored 
and feedback supplied to the treatment team. Feedback monitoring reports allow the 
treatment team to regularly assess the patient’s treatment progress and reassess expected 
outcomes as treatment continues. This feedback allows for the tailoring of individual 
treatment plans to consistently meet the unique and varied needs of each patient (Kordy 
et al., 2006). This approach allows for an integration of all of the successful therapy 
approaches for eating disorders and consistent monitoring and tailoring of these 
approaches to help patients obtain optimal treatment. Furthermore, should a patient be an 
early responder, patient monitoring will disrupt the cycle of the rule of diminishing 
returns by ensuring that a change in service provision will match patient needs.    
 The purpose of this investigation is to examine the effect of Individually Tailored 
Service Allocation on therapeutic outcomes in an eating disorder program. This study 
will use the Outcome Questionnaire–45 and the Outcome Questionnaire Analyst to assess 
patient progress and provide progress reports to therapists. In consideration of the 
literature reviewed, several questions present themselves: (a) Does treatment in a partial 
hospital program for eating disorders significantly affect global psychological 
dysfunction over time? (b) Does initial disease severity affect change in global 
psychological dysfunction over time? (c) Does provision of feedback about treatment 
response to therapists significantly affect global psychological dysfunction over time? (d) 
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Does feedback moderate the relationship between nonresponse to treatment and treatment 
outcome over time? (e) Does therapist receipt of treatment response feedback account for 
unique variance in differences in length of treatment? (f) Does feedback account for 
variations in the point at which global psychological dysfunction reaches its maximum ? 
(g) Does therapist receipt of treatment response feedback account for unique variance in 
the rate of change from the point of maximum global psychological dysfunction to 
discharge from treatment? 
 
 
Aims, Hypotheses, and Exploratory Questions 
 
Aim 1 
To examine change in global psychological dysfunction over the course of 
treatment in a partial hospital eating disorder program. 
  Hypothesis 1a. A significant decrease in average global psychological 
dysfunction will be observed over the course of treatment for patients in a partial hospital 
eating disorder program.  
  Hypothesis 1b. Significant interindividual differences in intraindividual change 
will be observed—that is, the pattern of change of individual patients will vary relative to 
the sample-level trajectory of change.  
Aim 2  
To examine the effect of the initial level of global psychological maladjustment 
on change in global psychological dysfunction over the course of treatment in a partial 
hospital eating disorder program. 
  Hypothesis 2. Initial disease severity will account for a significant amount of 
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variance in the hypothesized decrease in average global psychological dysfunction over 
the course of treatment. Decrease in global psychological dysfunction will be greater for 
patients with lower initial levels of disease severity. 
  Exploratory question 2. To what extent do low self-esteem, interpersonal 
problems, affective problems, perfectionism, and facets of disease severity impact change 
in global psychological dysfunction over the course of treatment? Of the facets shown to 
be related to change over the course of treatment, is the nature of the relationship such 
that more severe maladjustment impacts the decrease in global psychological 
dysfunction? 
 
Aim 3 
To examine the effect of enabling greater individualized tailoring of service 
allocation through provision of feedback about response to treatment on decrease in 
global psychological dysfunction over time in a partial hospital eating disorder program. 
Hypothesis 3a. Differential treatment outcomes in the form of between-individual 
rates of change will be shown for patients whose therapists receive feedback such that 
patients whose therapists receive feedback will demonstrate a significantly greater 
decrease in patient global psychological dysfunction as compared to those to whose 
therapists’ feedback is not provided. 
 Hypothesis 3b. Consistent with the notion of Individually Tailored Service 
Allocation (Kordy et al., 2006) in which patient information at intake is not considered 
wholly predictive of treatment outcome, therapist receipt of treatment response feedback 
will account for unique variance in between-individual rates of change. 
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Hypothesis 3c. Therapist receipt of feedback will moderate the relationship 
between nonresponse to treatment and treatment outcome over time such that 
nonrespondent patients whose therapists receive feedback will show a significantly 
greater decrease in global psychological dysfunction as compared to those to whose 
therapists’ feedback is not provided. 
 
Aim 4 
To examine the effect of enabling greater individualized tailoring of service 
allocation through the provision of feedback about response to treatment on length of 
treatment in a partial hospital eating disorder program. 
Hypothesis 4. Therapist receipt of treatment response feedback will account for 
significant unique variance in length of treatment in the partial hospital program (PHP) 
over and above that accounted for by disease severity at time of intake, such that total 
treatment length will be shorter for patients whose therapists receive feedback as 
compared to those to whose therapists’ feedback is not provided. 
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Methods and Analyses 
 
 
 The following section provides a thorough review of the methods and analyses 
utilized for this research investigation. First the demographics of the participating patients 
and clinicians will be presented, followed by an examination of the measures used. 
Finally, a comprehensive introduction to Hierarchical Linear Modeling concludes this 
chapter. 
Participants 
A total of 58 patients receiving treatment at the Valenta Inc., Eating Disorders 
Program (Valenta) participated in this study. Patients with fewer than six Outcome 
Questionnaire (OQ) measurement occasions (i.e., a minimum of 3 weeks of treatment at 
Valenta) were removed from the data set. Final data analysis included 51 adult women 
with a primary diagnosis of either anorexia nervosa or bulimia nervosa (Table 3). Patients 
ranged in age from 18 to 49 (M =24.14, SD = 7.03).  Upon intake, patients were 
administered a battery of assessments including the Outcome Questionnaire-45 (OQ-45) 
and Eating Disorders Inventory 3 (EDI-3). Demographic data were collected as part of 
the routine intake assessment interview. Patients were randomly assigned to one of the 
two treatment conditions: experimental (feedback) or control (no feedback). During the 
course of the study, the Outcome Questionnaire-45.2 was used to assess patient global 
psychological dysfunction twice a week. All patients completed the OQ-45 as part of 
their check-in procedures every Monday and Thursday morning throughout their course 
of treatment at Valenta. The OQ-45 was administered using a Dell Axim X5 Pocket PC 
with the Outcome Questionnaire Analyst (OQ-A) software.  
74 
Table 3 
Characteristics of Patients 
Variables N % x  SD Range 
Gender 
     Female 
 
51 
 
100% 
   
Diagnosis 
      Anorexia Nervosa 
      Bulimia Nervosa 
 
24 
27 
 
47.1% 
52.9% 
   
Age eating-disordered behaviors began   14.9 4.7 8-33 
Duration of eating disorder   9.5 6.6 1.3-27 
Number of outcome questionnaires   
      administered 
  25.8 11.4 6-53 
Eating Disorders Inventory– 3 
Composite Scales 
     Global Psychological Maladjustment  
     Ineffectiveness Composite 
     Interpersonal Problems Composite 
     Affective Problems Composite 
     Overcontrol Composite  
 
 
 
  
 
48.2 
48.2 
51.0 
48.1 
46.5 
 
 
6.9 
8.2 
7.3 
8.1 
8.8 
 
 
33-61 
31-64 
34-65 
32-68 
29-63 
 
 
 
Participating Clinicians 
Three therapists from Valenta participated in this study. Two were licensed 
marriage and family therapists, and the third therapist was a social worker. All therapists 
worked under the guidance of the Valenta Medical Director as well as with a nutritionist. 
The purpose of the study was explained to the participating therapists, and they were 
made aware that they would receive feedback on only half of their patient load. 
Assignment of patients to therapists was performed using routine intake procedures. It 
was assumed that the numbers of participants in the experimental and control conditions 
seen by each therapist were equal, and therefore no steps were necessary to alleviate 
potential therapist assignment effects. As indicated in Table 4, Therapist 3 was randomly 
assigned roughly 25% more patients who were in the feedback group than either 
Therapist 1 or Therapist 2. A multiple regression analysis was conducted to evaluate the 
prediction of therapist assignment and feedback group assignment on OQ change score.  
75 
Table 4 
Participant Assignment to Therapist and Feedback Groups 
  Feedback group 
  No feedback Feedback Total 
Measure  Count Row N % Count Row N % Count Row N % 
Therapist 1* 9 52.9% 8 47.1% 17 100.0%
2* 8 53.3% 7 46.7% 15 100.0%
3** 4 21.1% 15 78.9% 19 100.0%
* Marriage and Family Therapist 
** Social Worker 
 
 
R2 = .02, F(2, 48) = .49, p = .615. Neither therapist assignment nor feedback group 
assignment significantly predicted OQ change scores. A one-way analysis of variance 
was conducted to evaluate the relationship between therapist assignment and the OQ 
change score, assessing for overall change in global psychological dysfunction at 
treatment end. The analysis of variance (ANOVA) was not significant, F(1, 49) = .001, p 
= .98, indicating that therapist assignment did not result in a significant change in global 
psychological dysfunction. Based on these results, it has been assumed that the unequal 
distribution of the feedback and no feedback group patients amongst the therapists will 
have no significant impact on subsequent analyses. 
 
Measures 
The Outcome Questionnaire-45 (OQ-45) 
The OQ-45.2 is part of a quality management system developed by Lambert and 
colleagues (see Lambert, Hansen, et al., 2001) in 1996. It was developed in part from the 
work of Howard et al. (1986) examining the dose-effect relationship in therapy.  Lambert 
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and Hansen et al. (2001) use the OQ-45 as an operationalization of patient treatment 
outcomes. A brief, self-report measure, the OQ-45 is used to track both the magnitude 
and rate of change throughout the course of treatment (Brown, Burlingame, Lambert, 
Jones, & Vaccaro, 2001).  The questionnaire is composed of 45 questions, each based on 
a 5-point Likert scale (0 = never; 1 = rarely; 2 = sometimes, 3 = frequently; 4 = almost 
always) and results in scores ranging from 0 to 180. Patient progress, as assessed by the 
OQ-45, is based on monitoring three aspects pertinent to therapeutic outcomes: (a) 
subjective discomfort, (b) interpersonal relationships, and (c) social role performance. 
These three measurements result in three subscale scores. The OQ Total Score provides a 
global assessment of patient functioning (Lambert, Whipple, et al., 2001). 
Lambert and associates (1996; 2004) found the OQ to have adequate internal 
consistency (r = .93). The OQ also has a satisfactory test-retest value at the 3-week mark 
(r = .85; Lambert, Burlingame, et al., 1996; Lambert et al., 2004). The OQ also has 
normative data based on data collected throughout the United States (Lambert, 
Burlingame, et al., 1996; Lambert, Hansen, et al., 1996; Umphress, Lambert, Smart, 
Barlow, & Clouse, 1997). The OQ-45 is indicated to be reliable, valid, and sensitive to 
change (Lambert et al., 1998).  To facilitate the interpretation of scores, criteria for 
reliable and clinically significant change have been developed based on the criteria 
outlined by Jacobson, Follette, and Revenstorf (1984).  The cutoff point for 
differentiating between a normal and a dysfunctional state has been set at a score of 64, 
and the reliable change index has been calculated to be 14 points. Based on these criteria, 
patient outcome can be determined by comparing OQ-45 scores to previous feedback 
reports, as well as through examining projected outcome curves.  
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Feedback on Progress  
The OQ system enables the generation of feedback reports that can inform 
therapists of patient progress in treatment. Feedback reports take the form of a progress 
graph in which patient status is communicated using a system of color-coded feedback 
messages (see Figure 6). Decision rules for determination of feedback message are based 
on baseline OQ score, number of treatment sessions completed, and change from most 
recent OQ score as compared with the baseline score.  
In consideration of therapeutic progress, as indicated by decision rules, one of four 
feedback messages may be given (Lambert et al., 2001): 
White feedback: “The client is functioning in the normal range. Consider 
termination.” 
Green feedback: “The rate of change the client is making is in the adequate range. 
No change in the treatment plan is recommended.” 
Yellow feedback: “The rate of change the client is making is less than adequate. 
Recommendations: Consider altering the treatment plan by intensifying treatment, 
shifting intervention strategies, and monitoring progress especially carefully. This client 
may end up with no significant benefit from therapy.” 
Red feedback: “The client is not making the expected level of progress. Chances 
are she may drop out of treatment prematurely or have a negative treatment outcome. 
Steps should be taken to carefully review this case and decide upon a new course of 
action such as referral for medication or intensification of treatment. The treatment plan 
should be reconsidered.” 
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Figure 6. Sample OQ-A Feedback Report Provided to Therapists. 
 
 
As a result of the ease with which the OQ can be scored and the elegant simplicity 
of the system of decision, OQ scores can be graphed and appropriate feedback message 
determined quickly after administration, enabling the provision of prompt feedback on 
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patient progress to therapists. Through the use of tools for administration and scoring 
such as Outcome Questionnaire Analyst (OQ-A) software, it is possible to generate near-
instantaneous feedback. 
 
Eating Disorder Inventory-3 (EDI-3) 
The Eating Disorder Inventory – 3 (EDI-3; Garner, 2004) was created in 1983 to 
serve as a self-reported measure of attitudes and behaviors associated with bulimia 
nervosa and anorexia nervosa (Garner et al., 1983). In 1992, an update of the Eating 
Disorder Inventory (EDI) was released, the Eating Disorder Inventory – 2 (EDI – 2), 
which involved the addition of three provisional scales; the original eight scales remained 
intact. In 2004, Garner released the EDI – 3, which is an extension of the EDI and EDI – 
2. The EDI – 3 includes scales and composites of eating disorder behavior that have been 
recently noted in the literature as being common to eating disorder symptomatology. The 
EDI – 3 is composed of 91 items that make up 12 scales: 3 eating disorder-specific scales 
and 9 general psychological scales: drive for thinness, bulimia, body dissatisfaction, 
ineffectiveness, perfectionism, interpersonal distrust, interoceptive awareness, and 
maturity fears. The general psychological scales examine issues that are highly relevant 
to eating disorders but not specific to them. The new EDI also has the advantage of 
providing six composite scores; one is eating disorder-specific (Eating Disorder Risk), 
and the other five are general constructs (Ineffectiveness, Interpersonal Problems, 
Affective Problems, Overcontrol, General Psychological Maladjustment). 
The development of the EDI was based on the assumption that disordered eating 
is multidimensional in nature. In light of this, the EDI is composed of eight subscales that 
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assess either attitudes and behaviors associated with eating and weight or personality and 
psychological characteristics commonly found in eating-disordered individuals. The EDI 
– 3 can provide normative information on eating-disordered individuals who are between 
13 and 53. The EDI has been normed for all three DSM-IV-TR eating disorder diagnoses: 
anorexia nervosa (restricting type and purging type), bulimia nervosa, and eating disorder 
not otherwise specified. It has not been normed for obesity or binge eating disorder 
(Psychological Assessment Resources, Inc.). The EDI – 3 has strong test-retest stability 
coefficients. The median test-retest coefficient for the Eating Disorder Risk scales 
composite is .95, and the median test-retest coefficient for the General Psychological 
scales is .93 (Psychological Assessment Resources, Inc.).  
 
Predictor Variables 
 Primary independent variables will be effect of therapist receipt of feedback, 
response to treatment, and initial disease severity. A selected set of covariates will also be 
assessed. 
 
Feedback 
To assess the effects of feedback to therapists on patient progress in treatment, 
patients to whose therapists feedback is given will be compared to those about whom 
feedback of progress is not made available. The treatment variable of feedback is 
dichotomous and specifies participant randomization to either the experimental condition, 
in which therapists were provided consistent feedback about patient progress in 
treatment, or the control condition, in which no feedback was given to therapists. All 
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patients will complete the OQ-45 on a regular basis over the course of their treatment, 
and all OQ results will be recorded for each participant. However, only information for 
patients randomized to the experimental group will be available for therapist review. For 
patients assigned to the experimental group, therapists will receive computer-generated 
feedback reports (Figure 6) the same day that the questionnaire is administered.  
 
Initial Disease Severity 
The Global Psychological Maladjustment Composite (GPMC) of the EDI-3 will 
be used as the primary indicator of initial disease severity. Exploratory analyses will also 
consider the extent to which initial severity on facets of Global Psychological 
Maladjustment is predictive of treatment outcome. Specifically, the extent to which low 
self-esteem, interpersonal problems, affective problems, and perfectionism are predictive 
of treatment outcome will be assessed using the Ineffectiveness Composite, Interpersonal 
Problems Composite, Affective Problems Composite, and Overcontrol Composite, 
respectively. 
 
Covariates 
Previous investigations on eating disorder outcomes and/or treatment efficacy 
have identified numerous variables that may impact treatment outcomes (Fairburn, 
Cooper, Doll, & Welch, 1999; Fichter, Quadflieg, & Hedlund, 2006; Keel & Mitchell, 
1997; Lindberg & Hjern, 2003; Quadflieg & Fichter, 2003; Steinhausen, 2002). For the 
purposes of this study, three variables were identified following a review of the literature 
as having the largest possible impact on treatment outcomes. These variables are eating 
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disorder diagnosis (anorexia nervosa or bulimia), age of onset of eating disorder (age of 
initial symptom manifestation), and duration of eating disorder (number of years since 
symptom manifestation). In addition, the possible effects of therapist assignment will also 
be assessed. 
 
Outcome Variables 
Primary dependent variables included (a) change in global psychological 
dysfunction, (b) rate of change in global psychological dysfunction, and (c) length of 
treatment period. The Outcome Questionnaire-45 (OQ-45) was used as the measure of 
patient global psychological dysfunction. These three outcome variables were considered 
across time in treatment. For purposes of these analyses, time was defined in terms of 
number of OQ-45 check-ins, or “measurement occasions.” For this study, measurement 
occasions of OQ-45 data were collected biweekly from patients (Monday and Thursday). 
If a participant was missing data for a measurement occasion over the span of her 
treatment, it was assumed that the data were missing at random. The outcome variables 
were evaluated across periods of treatment, including over the entire treatment course 
(i.e., time from treatment intake to discharge).  
 
For Evaluation of Outcome for Total Course of Treatment 
The OQ-45 data obtained across the participant treatment course yielded a 
hierarchically nested data structure, with the participant’s biweekly OQ-45 scores nested 
within the randomized feedback condition. Hierarchical linear modeling (HLM; Version 
6.0.6; Raudenbush, Bryk, Cheong, & Congdon, 2004) was used to evaluate participant 
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outcome for the total course of treatment. Following data cleaning and preparation for 
analyses, within-participant regressions were performed, and then the resulting regression 
coefficients were modeled as a function of the between-participant conditions, 
assignment to a feedback or no-feedback condition. In other words, the HLM analyses 
involved modeling the within-subjects (participant’s biweekly OQ-45 scores) variance at 
Level 1 and between-subjects (or feedback condition) variance at Level 2 (Raudenbush & 
Bryk, 2002). HLM was chosen for these analyses for its superior ability to manage data 
that are collected longitudinally but at varying intervals and for its ability to manage 
multiple covariance structures (Gibbons, Hedeker, Elkin, Waternaux, Kraemer, 
Greenhouse, et al., 1993). 
Hierarchical linear modeling typically consists of a level of within-subjects 
factors (Level 1) nested in another level of between-subjects factors (Level 2). Level 1 
represents the relationship between some measure of time (i.e., OQ Administration 
Number) and the outcome variable for each participant (i.e., Total Score of OQ-45 for 
each administration). While it is possible to have more than one outcome variable, for the 
purposes of this investigation, only one outcome variable was identified to be analyzed. 
The analysis of each Level 1 variable resulted in regression coefficients. The within-
subjects regression coefficients were estimated using the following equation: 
OQ-45 Scoreij = β0j + β1j(OQ-45 Measurement Number)ij+ rij. 
In this equation, OQ-45 Scoreij represents the participant’s final OQ-45 score at discharge 
for participant j at OQ-45 measurement number I. For each individual j, the intercept is 
represented by β0j and the within-subjects slope is represented by β1j. 
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Level 2 variables of the HLM analysis are the invariant predictor variables that 
define the relationship between the Level 1 variables as well as the estimated parameters 
from the Level 1 intercepts and slopes. For example, the patients who participated in this 
study were randomly assigned to either a control group or an experimental group. Group 
membership is an invariant variable (e.g., once in an assigned group, patients were never 
switched to the other group). As discussed in the literature review, therapist receipt of 
feedback on patient progress has been shown to positively influence patient outcomes in 
treatment (Harmon, Hawkins, Lambert, Slade, Whipple, 2005; Lambert, 2005; Lambert, 
Whipple, Smart, Vermeersch, Nielsen, et al., 2001; Lambert, Whipple, Vermeersch, 
Smart, Hawksin, et al., 2002; Lambert Ogles, 2009). If the covariate, or predictor, 
variable is patient assignment to feedback condition, then the results of the Level 2 
equation, in which the Level 1 outcome variable (TotalScore) and time variable 
(SessNum) are nested, would represent the initial OQ score at intake and the rate of 
change throughout treatment as influenced by patient assignment to a feedback condition. 
Across-treatment change in global psychological dysfunction was defined as 
β (i0- ij )i  = β0j + β ij+ rij. 
in which, for participant j, β0j is the OQ-45 score at baseline, β ij is the final OQ-45 score 
before discharge, and β (i0-ij )i  is the change between the scores at baseline and discharge. 
Within-subjects error variance is represented by rij . Across-treatment rate of change in 
global psychological dysfunction is defined as HLM slope from treatment entry (baseline 
or β0j) to discharge (final measurement occasion or βij ). The length of treatment period is 
defined as number of possible OQ-45 measurement occasions from treatment entry 
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(baseline or β0j) to discharge (final OQ-45 score or βij).  
Hierarchical linear modeling allows for the Level 1 regression coefficients to be 
modeled at another level. The Level 1 regression coefficients were modeled at Level 2 as 
a function of between-subjects differences based on the feedback condition and initial 
level of global psychological dysfunction.  This second level is represented by the 
following equation: 
β0j = γ00 + γ01j + γ02j + u0j 
β1j = γ10 + γ11j + γ12j 
In the between-subjects model, β0j through βij represent, respectively, the within-subjects 
intercepts and slopes. The means of  βij within-subjects regression coefficients are 
represented by γ0s, covarying for the possible between-subjects effects of number of OQ 
administrations and feedback condition. The errors of the β.js were represented by their 
respective u.js and the variances are represented by the between-subjects error variances. 
 
HLM Intercept-only Model 
The intercept-only model, also known as the one-way ANOVA model with 
random effects or unconditional model, is used to establish a baseline. The Level 1 and 
Level 2 models are then compared to it. The intercept-only model equation is as follows: 
β0j  = β0 + ri 
The intercept-only model revealed an intraclass correlation coefficient of .83. Thus, 83% 
of the variance in OQ-45 scores was between-subjects (feedback versus no-feedback 
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groups), and 17% of the variance in OQ-45 scores was at the student level. Because 
variance existed at both levels of the data structure, predictors were added to each level 
individually. 
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Results 
 
 
 This chapter begins with a review of the mechanisms utilized for data preparation 
and review.  Next, the outcomes of the data screening and characteristics of the data 
utilized in the Hierarchical Linear Models are presented. This chapter closes with step-
by-step presentation of the results of each Hypothesis and Exploration Question. 
 
Data Screening 
All variables of interest were screened for multivariate assumptions. Variables 
that presented as significantly skewed, leptokurtic, or platykurtic were transformed 
logarithmically and screened again.  Additionally, all variables were assessed for outliers. 
For the purposes of this investigation, an outlier was defined as any variable with a z-
score greater than 3.29. Three individuals were indicated to have outliers on at least one 
measurement. Taking into consideration the already small sample size of this study, 
alternate methods for managing the outliers without having to remove patients from the 
data were considered. Based on the suggestion of Tabachnick and Fidell (1996), analyses 
were run with and without the patients who had the outliers to assess the impact of the 
outliers on the results. The outliers were not found to change the results of the analyses, 
and therefore no patients were removed from this study due to possessing an outlying 
variable within their data. The correlations between participant age, primary diagnosis 
(AN or BN), total number of OQ administrations, OQ change score, and EDI-3 
composite subscale Global Psychological Maladjustment variables were low, thus 
alleviating concerns of multicollinearity (see Table 5). The correlations between 
participant age, duration of eating disorder, and age eating disorder began were 
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Table 5 
Correlation Table of Variables Used in Analyses 
Variable 
Age 
at 
intake 
Duration 
of EDO D 
Therapist 
assignment 
Age 
at 
EDO 
onset 
Length of 
treatment IC IPC APC OC GPMC 
Participant Age at Intake 1.000           
Duration of Eating 
Disorder 
.729** 1.000          
Diagnosis .233 .311* 1.000         
Therapist Assignment -.199 -.100 -.143 1.000        
Age of Eating Disorder 
Onset 
.506** -.193 -.046 -.209 1.000       
Length of Treatment -.100 -.115 .070 -.196 .012 1.000      
Ineffectiveness 
Composite 
.152 .154 .195 -.048 -.017 -.051 1.000     
Interpersonal Problems 
Composite 
.190 .120 .029 -.106 .108 .042 .754** 1.000    
Affective Problems 
Composite 
.167 .154 .367** -.021 -.008 .013 .459** .285* 1.000   
Overcontrol Composite .228 .242 -.011 .027 -.082 .062 .131 .159 .308* 1.000  
Global Psychological 
Maladjustment 
Composite 
.187 .199 .323* .015 -.062 .004 .568** .448** .821** .510** 1.000 
**. Correlation is significant at the 0.01 level (2-tailed). 
  *. Correlation is significant at the 0.05 level (2-tailed). 
 
significant, as was expected. The correlations between the composite subscales of the 
EDI-3 were also significant, as expected.  
Data were screened for missing data, and six instances of missing data were 
identified. Due to HLM not allowing for missing variables at Level 2 and age variables 
being Level-2 data, mean substitution was used to replace missing data. Mean 
substitution was utilized in order to preserve as much available data for analysis as 
possible and, due to the low number of missing data points, the possibility of the mean 
substitution resulting in a significant change in the values of the variables’ correlations 
was low. This concern was addressed through examining correlation matrices before and 
after implementing mean substitution for the missing data. There was not a significant 
change between the correlation matrices.  
89 
Normality assumptions for all output variables were assessed through an 
examination of each variable’s frequency plot of the distribution. Both nontransformed 
and log-transformed variables appeared to be approximately normally distributed. Prior 
to analyzing the data for HLM, each variable was assessed to ensure that it met the 
primary assumptions of HLM. The two key assumptions are that the dependent variable 
is normally distributed and that there is a linear relationship between the dependent and 
independent variables (Raudenbush, 2004). The variable (TotalScore), representing the 
unique total score of each OQ administration, violated the assumptions of normality (p < 
.000). The variable was transformed using a loglinear transformation, which resulted in 
the variable being normalized and meeting the criteria for normality (p > .05). To assess 
the assumption of linearity, the session number (SessNum) variable was examined with 
TotalScore as the dependent variable to assess for a linear relationship. SessNum was 
chosen for this task as previous research has typically found number of treatment sessions 
to be a predictor of better treatment outcomes (Howard et al., 1986). An examination of 
the scatterplots representing the relationship between TotalScore and Sessnum indicated a 
linear relationship between the variables. Therefore, the data met the key assumptions of 
HLM. 
The model-building process for the HLM began with an assessment of the 
intercept model, which was composed of only the outcome variable (TotalScore) and the 
time variable (SessNum). The intercept model indicated whether the patients experienced 
change across the course of treatment. Had the analysis of the intercept shown there to be 
no variability, no subsequent HLM analyses would have been conducted. The intercept 
model indicated significant change across the course of treatment (see Figure 7 and Table 
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6), and subsequent predictor variables were sequentially added to the model in order to 
explain the remaining variance in the relationship between the Level 1 variables. As each 
variable was added, the model was examined to assess for significant change in the 
amount of residual error. If a variable resulted in a significant reduction of residual error, 
it was thus assumed to account for a significant level of variance in the model. Variables 
that did not explain variance in the model were removed. The resulting model was 
composed of the independent variables feedback condition and the EDI-3 Global 
Psychological Maladajustment Composite score. The final model was represented by the 
following equation: 
Level 1: β0j  = β0 + β1(SessNum) j + ri 
Level 2: β0j = γ00 + γ01(Feedback Group)j + γ02(EDI-3 GPMC Composite)j + u0j 
   β1j = γ10 + γ11(Feedback Group)j + γ12(EDI-3 GPMC Composite)j 
 
Analyses of Hypotheses and Exploratory Questions 
Hypothesis 1a 
A paired-samples t test was conducted to compare subjects’ OQ scores at intake to 
their OQ scores at the time of discharge as a measure of change in psychological 
dysfunction. There was a significant difference between the OQ intake scores (M = 81.86, 
SD = 24.72) and OQ discharge scores (M = 72.02, SD = 27.45); t(50) = 3.16, p = 0.003. 
These results indicate that there was significant change in subjects’ intake and discharge 
OQ scores. Specifically, these results suggest that global psychological dysfunction 
significantly decreased over the course of treatment (Figure 7).  
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 The course of symptom change over treatment course was also assessed through 
evaluation of significance of the HLM slope fixed-effects estimates. As indicated in 
Table 7, patients started treatment with an average OQ score of 80.77 and became 
significantly better by an average of 0.37 points per OQ-45 administration (p < .05). 
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Figure 7. Mean change in OQ Score Across 
Treatment Course for All Patients. 
 
 
 
 
Table 6  
HLM Parameters of Course of OQ-45 Scores Over Time in Treatment 
for All Patients 
Effect Notation Coefficient SE T-ratio P-value 
Intercept β00 80.77 3.86 20.70 0.000 
Slope β10 -0.37 0.15 -2.58 0.016 
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Hypothesis 1b 
 Interindividual differences in intraindividual change were assessed through an 
evaluation of the random-effects estimates of the HLM slope at Level 1 of the 
hierarchical analysis. Both the intercept and number of OQ administrations were found to 
be reliable predictors of OQ-45 change scores; the reliability estimates equaled 0.97 and 
0.84, respectively. The random-effects estimates of the HLM slope at Level 1 were 
significant (p < .0005), and therefore the null hypothesis was rejected. The intraclass 
correlation was examined with the following equation: 
Yij = μ + αi + εij. 
Significant interindividual differences in intraindividual change were noted; the pattern of 
change in individual patients did vary relative to the sample level trajectory of change. In 
other words, patients in the feedback group significantly varied in their change 
trajectories from those in the nonfeedback group (interindividual variability) but had 
similar change trajectories to other patients within their assigned feedback condition 
(Müller & Büttner, 1994). Results of the intraclass correlation indicated that 86% of the 
variance in patients’ change in global psychological dysfunction is attributed to the 
between-subjects effect on mean TotalScore.  
   The results for Hypotheses 1a and 1b indicate that overall, participants’ OQ-45 
scores varied across OQ administrations, indicating that patients did experience a change 
in global psychological dysfunction during the course of treatment. These change patterns 
were indicated both interindividually and intraindividually. The model is not complete, 
however, as the within-subjects variance component is reported as significantly different 
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from zero. Other predictor variables needed to be added to the model to account for the 
remaining variance. 
 
Hypothesis 2 
  A two-way repeated measures, within-subjects analysis of variance was conducted 
to evaluate the effect of initial disease severity at the time of intake on patient treatment 
outcomes. The within-subjects factors were the patient OQ scores at intake and discharge. 
The EDI-3 Global Psychological Maladjustment Composite and total number of OQ 
administrations were covariates in the analysis. The interaction and main effects were 
tested using the multivariate criterion of Wilk’s Lambda (Λ ). Results of the repeated 
measures ANOVA indicated that initial disease severity does not have a significant effect 
on the average change of global psychological dysfunction at Time 1, intake, and Time 2, 
discharge, Λ = .97, F(1, 47) = 1.62, p =.21, η2 = .03, nor does the number of OQ 
administrations, Λ = .99, F(1, 47) = .52, p = .48, η2 = .01. These results indicate that 
neither initial disease severity nor time in treatment have a significant relationship with a 
patient’s change in global psychological dysfunction when one is examining patient 
intake and discharge outcomes. 
  The EDI-3 Global Psychological Maladjustment Composite scale was not 
indicated to have a significant effect on change in average global psychological 
dysfunction between intake and discharge outcome scores when examined with repeated-
measures ANOVA. An analysis of the intercepts-and-slopes as outcomes model utilized 
GPMC to predict the Level 1 intercept and Level 1 slope of a patient’s global 
psychological dysfunction through her course of treatment. GPMC was a significant  
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Table 7 
Final Estimations of Fixed Effects for the Conditional Model 
 
Fixed Effect Coefficient SE T-Ratio P-Value 
Intercept β0     
    Intercept1 83.24 4.36 19.10 0.000 
    GPMC 1.60 0.49 3.27 0.002 
    FB Group -10.13 6.83 -1.48 0.144 
Slope β1     
    Intercept2 -0.08 0.04 -2.06 0.039 
    GPMC -0.01 0.00 -2.48 0.014 
    FB Group -0.20 0.08 -2.39 0.017 
 
 
predictor of the Level 1 intercept t(48) = 3.27, p =.002. Overall, initial disease severity 
does significantly predict global psychological dysfunction at intake (Table 7). 
 
Exploratory Question 2 
A two-way repeated measures, within-subjects analysis of variance was conducted 
to assess the extent to which self-esteem, interpersonal problems, affective problems, and 
perfectionism moderate patient change in global psychological dysfunction between 
intake and discharge. The within-subjects factors were the patient OQ scores at intake 
and discharge. The EDI-3 composite scores for Ineffectiveness, Interpersonal Problems, 
Affective Problems, and Overcontrol were analyzed as covariates. The interaction and 
main effects were tested using the multivariate criterion of Wilk’s Lambda (Λ ). Results 
of the repeated-measures ANOVA indicated EDI-3 composite scores for Ineffectiveness, 
Λ = .99, F(1, 45) = .54, p = .47, η2 = .01, Interpersonal Problems, Λ = .99, F(1, 45) = 
.19, p = .67, η2 = .00, Affective Problems, Λ = 1.00, F(1, 45) = .08, p = .78, η2 = .01, and 
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Overcontrol, Λ = .99, F(1, 45) = .65, p = .42, η2 = .01,  do not significantly moderate the 
patient change in global psychological dysfunction between intake and discharge. These 
results support the removal of these predictor variables from the HLM. 
 
Hypothesis 3a 
An ANOVA was conducted to determine whether feedback condition moderates 
the patient change in global psychological dysfunction between intake and discharge. 
Feedback condition was the primary predictor, and pre- to post-treatment OQ change 
scores was the outcome variable. ANOVA results indicate that feedback condition does 
not account for a significant amount of variance in the change in OQ scores administered 
at intake and discharge F(1, 49) = 0.001, p = .98.  
 
Hypothesis 3b 
To determine if therapist receipt of feedback significantly predicts treatment 
outcome, the Level 1 HLM slopes were examined. Level 1 of the HLM was represented 
by the following equation: 
OQ Score  = β0 + β1(OQ Measurement Number) + r 
and Level 2 was represented by the equation: 
β0j = γ00 + γ01(Feedback Group)j + γ02(GPMC)j  
  β1j = γ10 + γ11(Feedback Group)j + γ12(GPMC)j.   
Differences in the average rate of decrease in global psychological dysfunction between 
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feedback conditions, after controlling for initial disease severity, were evaluated through 
a comparison of t ratio analyses. The feedback condition was a significant predictor of 
change in individual global psychological dysfunction across the course of treatment, 
t(1309) = -2.39, p = .017. These results indicate that feedback condition can significantly 
predict an individual’s change in global psychological dysfunction over the course of 
treatment. Patients in the feedback condition improved their total OQ-45 score an average 
of 0.20 per OQ-45 administration compared to patients not in the feedback condition. 
 
Hypothesis 3c 
The intercepts of the Level 2 HLM variables were examined using t-ratio analyses 
to assess whether placement in the feedback condition impacted patient global 
psychological dysfunction. The analysis of the relationship between feedback group 
assignment and OQ-45 score at intake was not significant, t(48) = -10.13, p = 0.144 
(Table 8). These results indicate that patients’ OQ-45 scores at intake were not 
significantly different. Therefore, changes in the relationship between OQ-45 scores and 
feedback condition that occur during the course of treatment would be related to the 
impact of feedback group assignment and not caused by the initial assignment to either 
feedback condition. 
 
Hypothesis 4 
Variation in total treatment duration at Valenta attributable to therapist receipt of 
treatment response feedback, beyond the variation accounted for by disease severity, was 
assessed by an analysis of covariance (ANCOVA) with feedback condition as the 
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primary predictor, EDI global psychological maladjustment as a continuous covariate, 
and total number of OQ administrations as the dependent variable. The ANCOVA was 
significant F(2, 48) = 4.18, p = .05. The feedback condition was significant after 
controlling for EDI-3 global psychological maladjustment. The hypothesis that, after 
consideration of initial disease severity, patients whose therapists receive feedback have 
shorter treatment duration was not confirmed, however. Results of the ANCOVA indicate 
that patients whose therapists receive feedback have a longer course of treatment than do 
patients whose therapists do not receive feedback (Figure 8). 
 
  
 
Figure 8. Mean Number of Total OQ Administrations by Feedback Condition.  
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Discussion 
 
 
 This final chapter of this investigation into the impact of individually tailored 
service allocation opens up with a review of the importance of identifying for effective 
treatments for eating disorders. A discussion of the results of this investigation and their 
meaning and possible significance for the successful treatment of eating disorders follors. 
The chapter closes with important methodological considerations for this research 
investigations and, finally, closes with  discussion of future areas for research relating to 
the problems presented herein.   
This investigation was designed to evaluate the impact of Individually Tailored 
Service Allocation on eating disorder treatment outcomes. The design and 
implementation of successful eating disorder treatment rely not only upon understanding 
the risk factors and etiology of these life-destroying disorders, but also on examining the 
symptom course, particularly within a treatment setting. This is particularly true given the 
complexity of the many varied risk factors that may lead to the development of an eating 
disorder. As indicated by the breadth of information included in the literature review for 
this investigation, there have been hundreds of studies examining risk factors, etiologies, 
treatment strategies, treatment outcomes, and a multitude of combinations of these 
factors. One oft-overlooked entity, though, is the course of patient symptom presentation 
throughout the course of treatment.  
As highlighted earlier, a wide range of treatment strategies for eating disorders 
exist, but the effectiveness of the treatment strategies remains low. Some researchers 
posit that as few as 50% of individuals with bulimia nervosa (Agras, 1993; Kordy, 2002; 
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Wilson, 1996) and 40% of individuals with anorexia nervosa (Kordy, 2002) will reach 
recovery. Such low numbers prove further investigation into existing treatment methods 
is needed. Complications with treatment are often related to the difficulty in defining the 
etiology of eating disorders as well as the role of societal and cultural factors. 
Researchers appear to have reached consensus regarding the importance of cognitions 
and interpersonal relationships in the maintenance of bulimia. However, many clinicians 
and researchers also report reaching an impasse when trying to identify which forms of 
therapy are most appropriate for anorexia. For example, Nevonen and Broberg (2006) 
suggested that IPT is more effective with bulimic individuals struggling with impulsivity 
and affective instability, whereas CBT is the treatment of choice for those whose EDO 
has an origin in body image, eating concerns, and a focus on weight. 
Unfortunately, these different aspects of an individual’s eating disorder may not 
emerge until late in treatment. Tobin and associates (2007) reported that 98% of 
clinicians who specialize in the treatment of eating disorders use an eclectic treatment 
approach in lieu of a standardized treatment manual. Empirically validated outcome 
strategies are almost impossible to assess in such a varied and diverse treatment arena. 
Yet with an almost 50% recovery rate for individuals with an eating disorder, it is clear 
that someone is doing something right in terms of eating disorder treatment. The real 
dilemma may not be which standardized treatment strategy a clinic or provider should 
adopt as the primary course of eating disorder treatment; instead, it may be how a 
clinician appropriately assesses which individual treatment strategies will most 
effectively treat this unique patient’s eating disorders. Thus far, current research has only 
focused on outcome data or compared symptom level at intake with that at discharge. 
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Both strategies merely highlight success or failure in treatment and do not allow for 
clinician intervention based on the collected outcome data.  
The results of this study indicate that variability in levels of global psychological 
dysfunction throughout the course of treatment appear to be the norm, rather than an 
exception, and this variability is related to eating disorder treatment outcomes. 
Interestingly, despite the widely documented recognition of several key risk factors for 
eating disorders as well as key predictors of treatment outcome, only initial global 
psychological maladjustment and feedback group assignment were indicated as 
significant predictors of treatment outcomes.  
Global psychological maladjustment as measured by the global composite scale of 
the EDI-3 was a resilient predictor of treatment outcomes. Membership in the feedback 
group also had a significant effect on treatment, particularly over the course of treatment. 
Therapists may have been primed by patients’ scores on the GPMC and the correlating 
intake OQ-45 scores, which highlighted the unique psychological maladjustment and 
dysfunction, respectively, for each patient. This priming could have led to greater 
attunement to the patient’s symptom presentation and thus enhanced the possibility of a 
positive treatment outcome.  Patients whose therapists did not receive biweekly outcome 
reports on their treatment progress may not have benefited from the same level of 
awareness provided by the global psychological maladjustment and intake OQ-45 results, 
as there were not regular objective reminders of the patient’s current psychological status. 
This current investigation is relevant to previous research, as it clearly indicates 
that Individually Tailored Service Allocation serves to enhance treatment outcomes in an 
eating disorder treatment center. These results challenge popular notions that treatment 
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strategies need to be manualized and streamlined in order to not only get the best results, 
but also identify key variables for predicting treatment outcomes. Given the widely 
varied and complex etiology of an eating disorder, it is not surprising that treatment 
trajectory and treatment outcomes vary as a function of intraindividual differences within 
a group, or interindividual, context. Each individual maintained a unique treatment course 
with widely varying scores on the OQ-45, yet all participants in the feedback condition 
followed the same treatment course—in other words, participants had unique treatment 
trajectories as indicated by the OQ-45 scores across treatment course but had 
significantly similar treatment trajectories within their assigned feedback condition. 
The current study provides compelling evidence to suggest that eating disorder 
symptom manifestation and symptom regression do not follow a stable, linear course 
throughout treatment. Recognizing this variability and implementing treatment strategies 
specific to the unique symptom presentation of each patient appear to be a critical in 
reducing global psychological dysfunction.  Counter to the existing research literature 
(Kordy, Hannöver, & Richard, 2001; Kordy & Lutz, 1995), the current study found that 
when outcome data are examined in a purely linear fashion, important fluctuations in 
treatment course are lost.    
As highlighted by the notable discrepancy in the results for Hypothesis 2, the 
choice of an appropriate statistical procedure has an irrefutable ability to drastically shift 
the outcome of an investigation. Similarly, the choice of treatment methodology and level 
of Individually Tailored Service Allocation have the irrefutable ability to drastically shift 
treatment outcomes, as clearly indicated by the results of the investigation. The notion 
that eating disorder treatment is a linear process is clearly disputed by the results for 
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Hypothesis 2. Results examining the impact of global psychological maladjustment on 
the change in OQ scores from intake to discharge were not significant (p = .21), nor was 
number of OQ administrations (p = .48). According to the results of the within-subjects, 
repeated-measures ANOVA, neither initial disease severity nor time in treatment have a 
significant relationship with a patient’s change in global psychological dysfunction when 
one is examining patient intake and discharge outcomes. This statistical procedure 
represents a one-size-fits-all-approach to data examination, which is unfortunately the 
approach taken by managed care providers and insurance agencies when parsing out 
coverage for eating disorder treatment. Successful eating disorder treatment may hinge on 
regularly examining patient progress throughout the course of treatment. Typically, 
eating disorder treatment is designed to meet the standard demanded by insurance 
companies or by the treatment providers. If, however, patients do have unique treatment 
trajectories, then treatment does need to be tailored to match each patient (Agras et al., 
2001), allowing for the most effective use of therapeutic resources and the most 
beneficial treatment. The results for Hypothesis 4 provide support for individually 
tailored treatment allocation. These findings indicated that patients in the therapist 
feedback condition actually had a longer treatment course than those in the nonfeedback 
condition. This outcome is not likely to be looked upon favorably by healthcare 
organizations that are constantly seeking to reduce costs related to patient care. It will be 
important for researchers to continue to build the case that while longer treatment is more 
costly in the short run, the costs will be significantly lower if treatment is successful and 
future partial hospitalization or higher level care is avoided in the future.   
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Methodological Considerations  
There are several limitations to this study that warrant discussion. First, with a 
small sample size and lack of power, it may not have been possible to detect the 
psychological predictors that significantly predict rapidity of weight gain. Additionally, 
this study included a mostly homogenous sample of participants with regard to gender 
and ethnicity. While this sample is relatively consistent with those of other studies that 
have evaluated eating disorder populations, the results of this study are not generalizable 
to males and people of non-Caucasian ethnicities. Furthermore, all psychological 
measures consisted exclusively of self-report questionnaires. Due to the denial and 
ambivalence involved in this disorder, participants may have underreported their 
symptoms and difficulties. While patients were assured that their measures would remain 
confidential, they may have responded with the belief that their answers could have a 
possible impact on the length of time they spend in treatment. 
Another methodological limitation of this study pertains to the use of treatment 
duration as a measure of outcome. Although Valenta delineated similar treatment goals 
and discharge criteria for patients, a patient’s length of time in treatment is subject to 
external factors such as insurance, family concerns, financial stress, etc. Therefore, 
treatment duration is dependent on the physical and psychological health of the patient 
and includes external variables that are impossible to control methodologically. This 
investigation did not examine external factors that could have impacted treatment 
duration.  
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Areas for Future Research  
It is recommended that the current study be continued in order to increase sample 
size and strengthen the results of the investigation. It is the hope of this researcher that 
upon completion of this investigation, the results are utilized to inform treatment 
practices and support patients in receiving appropriate care. In particular, a significant 
amount of time and resources are utilized with the hope or aiding individuals with an 
eating disorder to achieve remission and recovery. The results of Hypothesis 4, which 
indicated that patients in the therapist feedback condition actually had a longer treatment 
course than those in the nonfeedback condition, are particularly provocative. This 
outcome is not likely to warrant applause from healthcare organizations that are 
constantly seeking to reduce costs related to patient care but may illuminate why current 
remission and reocovery rates are so dismal. Future research ought to continue to build 
the case that while longer treatment is more costly in the short run, in consideration of 
long-term outcomes, the costs will be significantly lower if treatment is successful and 
future partial hospitalization or higher level care is not warranted.   
The results of this investigation are easily generalized to the demographic 
population commonly served in eating-disorder treatment programs. It is important for 
future research to evaluate how treatment outcomes may differ in a population of 
minorities or males with eating disorders. A more diverse sample will also enable 
researchers to examine additional cultural and societal factors not considered in this 
investigation and their impact on eating-disorder treatment outcomes. Important 
psychological differences between ethnicity and gender could be vital in determining 
methods of eating-disorder intervention and treatment focus.  
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The data collected in this investigation adequately assessed patient progress 
throughout the course of treatment. It would be fruitful to examine the subscales of the 
OQ-45 throughout the course of treatment in order to assess for emerging interpersonal 
concerns, social role perceptions, and symptom distress (a measure of depression and 
anxiety; Lambert, Hansen, et al., 2001). This would provide both clinicians and 
researchers with additional information needed to examine the relationships between 
these different facets and treatment outcomes. Examining the OQ-45 subscales 
throughout the course of treatment may also provide clarification as to why several of the 
variables that have been previously found to significantly predict treatment outcomes 
(i.e., age of eating disorder onset, duration of eating disorder, etc.) were not found to be 
significant in this model. Along these same lines, the OQ-45 is a general measure of 
global psychological dysfunction and is not an outcome measure specific to the 
assessment of eating-disorder symptoms. Using a standardized measure for assessing 
eating-disorder symptoms at regular intervals during the course of treatment along with 
the OQ-45 would provide additional, crucial information about the change trajectory of 
eating-disorder symptoms throughout the treatment course as well as serve as another 
invaluable resource for clinical intervention. 
 Future research could also involve continuing to follow a patient’s treatment 
using the OQ-45 after she has completed treatment with Valenta and stepped down into a 
lower level of care such as outpatient individual therapy. Collecting this additional 
information, post-partial hospitalization, would enable researchers to assess changes in 
additional psychological variables as well as track whether improvements made during 
the course of treatment are maintained.  
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Finally, future research should also take into consideration the effects of other 
variables that have been defined in the literature as predicting treatment outcome. For 
example, 11 variables have been identified as primary predictors of treatment outcomes 
for individuals with anorexia nervosa: duration of the eating disorder, age of onset, 
family of origin, age at onset of menstruation, sexual problems, psychiatric comorbidity, 
perfectionism, impulsivity, self-evaluation, extroversion, and low body weight (Fairburn, 
Cooper, Doll, & Welch, 1999; Keel & Mitchell, 1997; Lindberg & Hjern, 2003; 
Quadflieg & Fichter, 2003; Steinhausen, 2002). These variables could possibly be 
assessed in conjunction with the OQ-45 biweekly administration or, should that prove too 
burdensome, at both intake and discharge, thus allowing for an assessment of overall 
change in symptom presentation throughout treatment. 
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